Posters

Poster Area

Posters will be presented in the Poster Area, which is located on the ground floor.
(see floor plan)

Posters

Posters will be presented on poster boards on a daily basis. Presenters are requested to be available for discussion of their posters on the day of their presentation during coffee, tea and lunch breaks. Please find the schedule underneath.

Topic		No’s on display
Monday, June 25
1.0 :	Structure and Governance of Blood Transfusion Services	P-001 – P-011
2.1 :	Donors and Blood Donation - Recruiting and Managing Donors	P-012 – P-073
2.2 :	Donors and Blood Donation - Rare donor programmes	P-073 – P-078
3.1 :	Haemapheresis – Donors	P-079 – P-097
3.2 :	Haemapheresis – Therapeutic	P-098 – P-110
3.3 :	Haemapheresis - Thrombotic Thrombcytopaenic Pupura (TTP)	P-111 – P-114
4.0 :	Blood Processing	P-115 – P-158
5.0 :	Plasma Derivatives and Fractionation	P-159 – P-164
6.0 :	Blood Safety-Transfusion Transmitted Disease (TDD)	P-165 – P-166
6.1 :	Blood Safety-Transfusion Transmitted Disease (TTD) - HIV	P-167 – P-178
6.2 :	Blood Safety-Transfusion Transmitted Disease (TTD) - Hepatitis	P-179 – P-234
6.3 :	Blood Safety-Transfusion Transmitted Disease (TTD) - Parasites	P-235 – P-244
6.4 :	Blood Safety-Transfusion Transmitted Disease (TTD) - Bacterial Contamination	P-245 – P-267

Tuesday, June 26
6.5 :	Blood Safety-Transfusion Transmitted Disease (TTD) - Nucleic Acid Amplification Technology (NAT)	P-268 – P-296
7.0 :	Pathogen Reduction/Inactivation	P-297 – P-322
8.1 :	Immunohaematology - Red Cell Immunology	P-323 – P-381
8.2 :	Immunohaematology - Platelet Immunology	P-382 – P-390
8.3 :	Immunohaematology - Granulocyte Immunology	P-391 – P-393
8.4 :	Immunohaematology - Molecular Testing	P-394 – P-403
8.5 :	Immunohaematology - Immune Haemolytic Anaemias	P-404 – P-410
9.1 :	Clinical Transfusion Practice - Massive Transfusion/Resucitation	P-411 – P-414
9.2 :	Clinical Transfusion Practice - Pediatric Transfusion Practice	P-415 – P-425
9.3 :	Clinical Transfusion Practice - Blood Subsitutes	P-426 – P-431
9.4 :	Clinical Transfusion Practice - Criteria/Guidelines	P-432 – P-451
10.0 :	Transfusion alternatives	P-452 – P-463
11.0 :	Haemostasis	P-464 – P-479
12.0 :	Haemovigilance	P-480 – P-500
13.0 :	Quality management	P-501 – P-513
14.1 :	Stem Cells - Peripheral Blood and Blood Bone Marrow Progenitor Cells	P-514 – P-523
14.2 :	Stem Cells - Umbilical Cord Blood Stem Cells	P-524 - P-529
14.3 :	Stem Cells - Cellular Therapies	P-530 – P-533
15.0 :	Tissue Banking	P-534 – P-535
16.0 :	Blood Inventory Management	P-536 – P-543
17.0 :	Emerging Technologies	P-544 – P-553
18.0 :	Evidence Based Transfusion Medicine	P-554 – P-556
19.0 :	Education in Transfusion Medicine	P-557 – P-562
21.0 :	Various	P-563 – P-569

Poster Mounting

Please mount your poster on the above mentioned day, between 08.00 and 10.00 hours. The number of your poster can be found in the final programme and/or abstract book which will be handed over to upon registration. There is a poster desk in the poster area. The staff at this desk can help you as well. Assistance and material for mounting the posters (tape, blue tack, etc.) will be available during these periods. Setting-up a poster generally takes at least 15 minutes.

Poster Material Removing

Material should be taken on the day of your presentation before 18.00 hours. according the above mentioned schedule. Material that has not been taken down by the author(s) in time will be removed and destroyed.

Responsibility for poster presentations

The Organising Committee does not assume any responsibility for material displayed on the poster boards.

MONDAY, JUNE 25

Poster Session Topic 1.0:

Structure and Governance of Blood Transfusion Services

P-001 THE COMMUNITY ROLE IN ENHANCEMENT OF VOLUNTARY, NON-REMUNERATED BLOOD DONATION IN THE NEW MILLENNIUM

A. Alamiri (Ministry of Health, Sharjah, United Arab Emirates)

P-002 POSITIVE IMPACT OF BLOOD DONORS TESTING IN A COUNTRY WITH LIMITED RESOURCES

S. Bogdanovic, N. Bujandric, M. Krga-Milanovic (Blood Transfusion Institute Novi Sad, Novi Sad, Serbia)

P-003 MULTILEVEL DECISION OF THE SPECIALISTS IN TRANSFUSION MEDICINE IN THE SYSTEM OF BLOOD SAFETY IN A COUNTRY WITH LIMITED RESOURCES

N. Bujandric, S. Bogdanovic, M. Krga-Milanovic (Blood Transfusion Institute Novi Sad, Novi Sad, Serbia)

P-004 BANC DE SANG I TEIXITS: THE BLOOD AND TISSUE BANK OF CATALONIA IS A VEIN-TO-VEIN ORGANIZATION

J. Cid, M. Garriga, E. Serra, P. Ortiz, L. Puig, R.P. Pla (Banc de Sang i Teixits, Barcelona, Spain)

P-005 PROPOSAL OF NATIONAL BLOOD POLICY IN REPUBLIC OF MACEDONIA

K. Dimitrovski (National Institute of Transfusion Medici, Skopje, Macedonia)

P-006 IMPACT OF THE UK FREEDOM OF INFORMATION ACT ON THE SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE (SNBTS)

M. Franklin, M. Higgins, L. Kidd (University of Glasgow, Glasgow, United Kingdom)

P-007 REORGANISATION AND EFFECTUAL LEADING IN NATIONAL BLOOD TRANSFUSION MEDICINE IN SERBIA

C. Gavrancic (Blood Transfusion Institute, Novi Sad, Serbia)

P-008 REQUIRED METHODS AND ASPECTS OF TRANSFUSIOLOGY IN THE PROCEDURE OF LIVER TRANSPLANTATION

T. Jakica, B. Gavrancic, M. Ilic, S. Vojvodic (Medical Faculty, Novi Sad, Serbia)

P-009 ANNUAL BLOOD NEED OF TURKEY

N. Solaz, S. Kemahli, S. Cin (Ankara University, Ankara, Turkey)

P-010 SOFTWARE TOOLS IMPROVING THE CONTINUITY OF MEDICAL SUPERVISION FOR CLINICAL HAEMATOLOGY RELATED HOME CARE

B. Spyropoulos, M. Botsivaly (Technology Education Institute of Athens, Athens, Greece)

P-011 EVOLUTION OF RUSSIAN BLOOD SERVICE

E. Zhiburt (Federal Blood Center, Moscow, Russian Federation)

Poster Session Topic 2.1:

Donors and Blood Donation - Recruiting and Managing Donors

P-012 VOLUNTARY, NON-RENUMERATED BLOOD DONATION: METHODS TO INCREASE AND RETAIN.

T.A. Adraktas, A. Sarantopoulos, S. Chrysochoou, E. Kalfa, A. Krini, M. Gavalaki, A. Karafoulidou (Laikon General Hospital, Athens, Greece)

P-013 VOLUNTARY BLOOD DONORS OF TURKISH RED CRESCENT BLOOD CENTERS : WHY DO THEY GIVE BLOOD?

A. Aksoy, U. Guzel, E. Ergen, L. Sagdur, K. Aksoy, K. Kirali (Turkish Red Crescent, Ankara, Turkey)

P-014 THE EFFICACY OF ESTABLISHING A DONOR HAEMOGLOBIN CLINIC IN THE KUWAIT CENTRAL BLOOD BANK

R.H. Al-Abdulrazzak, R. Al-Radwan, S. Sharawy, N. Al-Sanad, O. Sharawy (Kuwait Central Blood Bank, Hawally, Kuwait)

P-015 DEFERRAL RATE DUE TO ANEMIA IN BRAZILIAN BLOOD DONORS

L.A. Amorim, C.L.C. Lobo, M.M.N. Pêcego, D. Rodovalho, N.A. Faria, M.E. Lopes (Hemobras, Rio De Janeiro, Brazil)

P-016 NEW APPROACHES IN BLOOD DONOR MOTIVATION ACTIVITIES

G. Andonov, T. Makarovska-Bojadzieva, D. Dukovski, R. Kalamaras, M. Blagoevska, R. Grubovik, L. Mitevska, P. Gerasimova (Institute of Blood Transfusion, Skopje, Macedonia)

P-017 ROUTINE AND EMERGENCY EXTERNAL PUBLIC RELATIONS ACTIVITIES OF THE BLOOD TRANSFUSION INSTITUTE OF SERBIA – TWO YEARS SURVEY

G. Antuljeskov, I. Rodic, S. Draskovic (Blood Transfusion Institute of Serbia, Belgrade, Serbia)

P-018 STATISTIC PROFILE OF DONATIONS IN EXTREMADURA IN 2006

T. Arroyo Zabas, A. Toril Diaz, J.M. Brull Sabaté (Blood Bank of Extremadura, Mérida, Spain)

P-019 SOCIO-DEMOGRAPHIC CARACTERISTIC OF BLOOD DONORS IN NATIONAL INSTITUTE FOR TRANSFUSION MEDICINE IN SKOPJE REPUBLIC OF MACEDONIA IN 2006 YEAR

M. Blagoevska, R. Grubovic, G. Andonov, S. Useini, T. Makarovska, R. Kalamaras, E. Spirovska (National Institute for Transfusion Medic, Skopje, Macedonia)

P-020 IRON DEFICIENCY IN FREQUENT AND FIRST TIME FEMALE BLOOD DONORS

M. Boulahriss, N. Benchemsi (CHU Ibn Rochd, Casablanca, Morocco)

P-021 A NEW EDUCATION PROPOSAL: SERVICE-LEARNING IN THE PROMOTION OF BLOOD DONATION

G. Cortel (Banc de Sang i Teixits, Barcelona, Spain)

P-022 COMPARISON OF RETURN RATES OF TEMPORARILY DEFERRED DONORS WITH THOSE OF UNDEFERRED DONORS

G. Delage, S. Dubuc (Héma-Québec, St-laurent, Canada)

P-023 RARE BLOOD DONOR PROGRAMME IN GREECE

V. Fakitsa, S. Valsami, M. Papakonstantinou, P. Karida, G. Papadopoulos, E. Katsadorou, S. Giannoulea, H. Desilla, K. Kourenti, K. Staya, E. Sotiropoulou, K. Maltezis (Blood Trasfusion Center, Athens, Greece)

P-024 BLOOD UTILIZATION MANAGEMENT AND ACUTE HEART FAILURE IN A CHILD

V. Fakitsa, S. Valsami, E. Melissari, M. Papakonstantinou, G. Papadopoulos, K. Maltezis, E. Katsadorou, E. Katsadorou (Blood Trasfusion Center, Athens, Greece)

P-025 EXPERIENCES OF ALYX COMPONENT COLLECTION SYSTEM IN A MOBILE ENVIRONMENT

C. Falkner, S. Milner (NHS Blood & Transplant, Leicester, United Kingdom)

P-026 THE EVALUATION OF BLOOD DONOR DEFERRAL CAUSES

M. Fernández-Campa G-Bernardo, M. Chin T. Muon, M.H. Gonçalves (Instituto Português do Sangue, Coimbra, Portugal)

P-027 IMPROVING VNRBD RATES IN THE AMERICAS THROUGH THE IMPLEMENTATION OF THE CLUB 25 METHODOLOGY

N.G.P. Garcia de Paredes (International Federation of Red Cross, Panama, Panama)

P-028 DONORS RECRUITMENT: HOW TO APPROACH YOUNG PEOPLE

G. Garozzo, E. Fidone, P. Bonomo (AZ. Ospedaliera Civile-MP Arezzo, Ragusa, Italy)

P-029 THE IMPACT OF A DECREASE IN DONOR DEFERRAL PERIOD FROM 12 TO 6 MONTHS

R. Goldman, Q. Yi, W. Fan, F. O'Brien (Canadian Blood Services, Ottawa, Canada)

P-030 EDUCATING - AND PERSUADING - THE NEXT GENERATION OF BLOOD DONORS

J. Granato (America's Blood Centers, Washington, Dc, United States of America)

P-031 BLOOD DONATION IN A TIME-STARVED CULTURE: THE IMPACT OF TIME ON RETURN PROPENSITY

J. Granato, K. Rose (America's Blood Centers, Washington, Dc, United States of America)

P-032 BLOOD DONATION AMONG HIGH SCHOOL STUDENTS IN REPUBLIC OF MACEDONIA – 5 YEAR SURVEY

R. Grubovic, M. Blagoevska, M. Grubovic, R. Dukovski, G. Andonov, S. Useini, T. Makarovska, B. Todorovska (National Institute for Transfusion Medic, Skopje, Macedonia)

P-033 MOBILE BLOOD DONATION CAMPAIGN FOR VOCATION AREAS

G. Guzel, A. Aksoy, L. Sagdur, B. Ersan, Y. Ak, K. Kirali, S. Kobakoglu (Turkish Redcreccent, Ankara, Turkey)

P-034 HIV TESTING AS THE MOTIVATION FACTOR FOR BLOOD DONATION IN IRANIAN BLOOD DONORS

S. Haghighi (Mashad Blood Transfusion Organization, Mashad, Iran)

P-035 LOW FERRITIN LEVELS MAY PLAY A PROTECTIVE ROLE AGAINST ACUTE ISCHEMIC CARDIOPATHY IN BLOOD DONORS

C.I. Isernia, G. Di Domenico, L. Paesano, M. D'Onofrio, F. Varricchio, G.M. Leonardi, A. Della Corte, M. Mottola, E. Santoro, E. Biglietto, N. Pastore, E. Picardi (SIT S. Giovanni Bosco, Napoli, Italy)

P-036 THE SELECTION OF DONORS: OUR EXPERIENCE

C.I. Isernia, G.M. Leonardi, G. Di Domenico, L. Paesano, M. D'Onofrio, F. Varricchio, A. Della Corte, M. Mottola, E. Santoro, E. Picardi (SIT S. Giovanni Bosco, Napoli, Italy)

P-037 THE IMPACT OF POPULATION CHANGES ON BLOOD DONATIONS, A COMPARATIVE ANALYSIS OF THE DECADE 1996-2006

J. Jarana Molero, A. Roman Rodriguez, E. Franco Cama (Centro Regional de Transfusion Sanguinea, Sevilla, Spain)

P-038 INFLUENCE OF THE SEX AND FREQUENCY OF THE DONATION IN THE METABOLISM OF THE DONORS

A.I. Jimenez Del Bianco, R. Valentin, J. Alfaro, F. Monsalve, V.P. Padron (Centro Hemoterapia Castilla y Leon, Valladolid, Spain)

P-039 BLOOD DONORS’ DEFERRAL: WHICH ARE THE MAIN REASONS? (PRELIMINARY RESULTS)

E. Kalfa, D. Bertsias, T. Adraktas, H. Myriokefalitaki, M. Gavalaki, A. Karafoulidou (Laikon General Hospital, Athens, Greece)

P-040 CONTROL OF THE HEALTH CONDITION OF BLOOD DONORS WITH THE PRESENCE OF MARKERS OF HEPATITIS B AND C

N. Kamcev, J. Vitlarova, M. Kamceva, V. Dejanova (WU Trasfusiology; General Hospital-Stip,, Stip, Macedonia)

P-042 BLOOD DONATION ORGANISATION BY MEDICAL STUDENTS FOR PEDIATRIC PATIENS

S. Kemahli, N. Solaz, I. Ertem, H. Ayraler, B. Ozel (Ankara University Serpil Akdag Blood Cen, Ankara, Turkey)

P-043 BLOOD DONORS WITH TRANSFUSION HISTORY

M. Kolarova, M. Dudikova, E. Tesarova, M. Nenickova, S. Gallova, D. Bukackova, R. Pacasova (Faculty Hospital Brno, Brno, Czech Republic)

P-044 EFFECT OF SHORT-TERM FERROUS SULFATE ON IRON STORES IN FEMALE BLOOD DONORS

M. Maghsudlu, T. Zandieh, Gh. Togeh, S. Parandush, M. Rezaiani (Reseach Center - Blood Transfusion Org, Tehran, Iran)

P-045 FROM IDEA TO TRADICIONAL BLOOD DONOR SESSION

L. Mitevska, G. Andonov, R. . Dukovski, T. Makarovska-Bojadzieva, T. Makarovska-Bojadzieva, R. Kalamaras, M. Blagoevska, S. Useini (Institute of Blood Transfusion, Skopje, Macedonia)

P-046 LOW KNOWLEDGE'S LEVEL OF BLOOD DONORS IN BURKINA FASO (WEST AFRICA); A POTENTIAL RISK FOR BLOOD AND TRANSFUSION SAFETY

K.Y. Nebie, E. Kafando, H. Dahourou, S. Diallo, Y. Kientega, Y. Domo, K. Kienou, S. Ouattara, I. Sawadogo, L. Ky (Centre National de Transfusion Sanguine, Ouagadougou, Burkina-Faso)

P-047 REACTIONS OF VOLUNTARY BLOOD DONORS

B. Nikolic (Blood Transfusion Institute, Nis, Serbia)

P-048 DONOR HAEMOVIGILANCE IN JAPAN

H. Okazaki, K. Shuto, T. Araki, K. Tadokoro (Japanese Red Cross, Tokyo, Japan)

P-049 PROFILE OF THE DONOR OF BONY MARROW IN THE CTS-HUELVA IN 2007

P.P.G. Pepe, J.E. Guerra González, C. Martínez Sánchez, D. Prados Madrona, P. Pajaro, D. Fernández, J. Román (Centro de Transfusión Sanguínea, Huelva, Spain)

P-050 PROFILE OF THE DONOR OF PLAQUETOFÉRESIS IN THE CTS-HUELVA IN 2007

P.P.G. Pepe (Centro de Transfusión Sanguínea, Huelva, Spain)

P-051 ETHICAL AND PSYCHOLOGICAL IMPLICATIONS OF A CHILDREN’S COMPETITION IN RECRUITING VOLUNTARY BLOOD DONORS

I. Petrovic (University of Beograd, Faculty of Philos, Beograd, Serbia, Serbia)

P-052 EVALUATION OF CHILDREN’S COMPETITION AS A COMMUNICATION TOOL IN PROMOTING VOLUNTARY BLOOD DONATION

I. Petrovic, P. Kovacevic, M. Cankovic Kadijevic (University of Beograd, Faculty of Philos, Beograd, Serbia, Serbia)

P-053 STUDY ON DEMOGRAPHIC CHARACTERISTICS OF BLOOD DONORS WHO WERE DEFERRED FOR LOW HAEMOGLOBIN

P.L.H. Poo, T. Krishnasamy P, H.C. Goh, C.L. Toh, H.H. Tan (Health Sciences Authority, Singapore, Singapore)

P-054 ANALYSIS OF BLOOD DONORS DEFERRAL IN BLOOD TRANSFUSION SERVICES UNITED ARAB EMIRATES EXPERIENCE

Y.M. Raouf, A.H. Al Amiri (Ministry of Health, Sharjah, United Arab Emirates)

P-055 THE STUDY OF USEFULNESS OF BARCODE FOR DRAWING REJECTED BLOOD DONORS CONFIDENCE IN RESPECTING TO QUESTIONS WITH A SPECIAL FOCUS ON HIV

F. Razjou, M. Zadsar, M. Yahyapur (Iranian blood transfusion research cente, Tehran, Iran)

P-056 PROMOTION OF VOLUNTARY, ANONYMOUS, NONREMUNERATED AND REGULAR BLOOD DONOATION IN BELGRADE STUDENTS POPULATION FROM 2001 TO 2006

R.I. Rodic, A.G. Antuljeskov, D.S. Draskovic (Blood Transfusion Institute of Serbia, Belgrade, Serbia)

P-057 EVALUATION OF PREOPERATIVE AUTOLOGOUS BLOOD DONATION IN ELDERLY PATIENTS IN A BLOOD BANK IN ARGENTINA

E. Rodriguez, R. Fernández, G. Amerise, A. Skripnik Strelecki (Fundación Hemocentro Buenos Aires, Buenos Aires, Argentina)

P-058 INCREASE OF DONATIONS AFTER THE APLICATION OF THE REAL DECRETO 1088/2005 IN SPAIN

P. Rodriguez Solis, M.T. Hernandez Ruiz, E. Ruiz Herrador, Y. Pluma Mañueco, C. Hernandez Garcia, J.M. Brull Sabate (Blood Bank of Extremadura, Merida, Spain)

P-059 IRON STATUS IN BLOOD DONORS

A.S. Røsvik, T. Wentzel-Larsen, T.H. Hervig, T.J.U. Ulvik (Institute of Life Sciences, Aalesund, Norway)

P-060 INCIDENCE AND PREVENTION OF VASOVAGAL SYNDROMES IN BLOOD DONORS

R. Ruiz Roman, P. Romero Anaya, A. Roman Rodriguez, J.G García Masegoso, J.J Jarana Molero, E.F Franco (C.R.T.S de Sevilla y Huelva, Sevilla, Spain)

P-061 THE CHOICE OF BECOMING A BLOOD DONOR: ANALYSIS OF 1036 QUESTIONNAIRES SUBMITTED TO "AVIS (ITALIAN VOLUNTEER BLOOD DONORS ASSOCIATION) SOVRACOMUNALE MEDIO VARESOTTO" BLOOD DONORS

V. Saturni, A. Cardani, G. Tamanza (Avis Regionale Lombardia, Milano, Italy)

P-062 THE CONTRIBUTION OF AVIS (ITALIAN VOLUNTEER BLOOD DONORS ASSOCIATION) REGIONALE LOMBARDIA TO SELF-SUFFICIENCY OF BLOOD AND HEMOCOMPONENTS

V. Saturni (Avis Regionale Lombardia, Milano, Italy)

P-063 INCONSISTENCY IN THE RESPONSES OF REGULAR DONORS TO HEALTH HISTORY QUESTIONS

H. Sayers (Carter BloodCare, Bedford, Texas, United States of America)

P-064 DISRIBUTION OF THE BLOOD GROUPS O, A, B, AB AND D IN BLOOD GROUP SYTEMS ABO AND RH WITH POPULATION IN KUMANOVO REGION

Lj. Slavkovska (City Hospital, Kumanovo, Macedonia)

P-065 WOMEN-BLOOD DONORS IN THE MUNICIPALITY OF KUMANOVO

Lj. Slavkovska (City Hospital, Kumanovo, Macedonia)

P-066 TRACKING OF HEMOGLOBIN AND FERITINE LEVEL IN VOLUNTARY BLOOD DONORS IN BLOOD TRANSFUSION INSTITUTE NIS

I. Stanojevic, Z. Stanojkovic, S. Stevanovic (Blood Transfusion Institute Nis, Nis, Yugoslavia)

P-067 ASSESSMENT OF A SELF-DEFERRAL SCREENING FORM AMONG BLOOD DONORS AT CHIANG MAI UNIVERSITY HOSPITAL, THAILAND

L. Thaikruea, N. Nantachit, N. Leetrakoo, L. Fongsatitkul, P. Sompan, A. Heaton, K. Nelson (Chiang Mai Faculty of Medicine, Chiang Mai, Thailand)

P-068 VISTA INFORMATION SYSTEM: PRACTICAL AND FINANCIAL EFFECTS ON VALUE AREAS AND ON PRODUCTIVITY THROUGH THE CREATION OF DONOR GROUPS. EXPERIENCES FROM THE NATIONAL BLOOD SERVICE IN SOUTHAMPTON

A. Thompson, F. Hofman (NHSBT Southampton, Southampton, United Kingdom)

P-069 PRE-DONATION INTERVIEW: A TOOL FOR PREVENTING THE VERTICAL HIV TRANSMISSION

W. Torres, M. Ortiz de Zárate, F. Oliveto, P. Trevini, A. Quinteros, A. Quinteros, A. Frías, M. Maestri (Hospital Materno Infantil Ramón Sardá, Ciudad De Buenos Aires, Argentina)

P-070 THE CAUSES OF INCOMPLETE BLOOD DONATIONS

V. Urlep S˜ alinovic, L. Lokar, I. Maracic (Maribor Teaching Hospital, Maribor, Slovenia)

P-071 LOSSES OF THE SUPPLY OF DONATED BLOOD DUE TO DONOR DEFERRAL, MISCOLLECTION AND LAPSED DONORS

V.N. Vavic, M.S. Milutinovic, M.D. Mircetic, C.V. Cosovic, I.J. Istatkov, J.I. Jeremic, D.R Dinic, D.S. Draskovic (Blood Transfusion Institute of Serbia, Belgrade, Serbia)

P-072 FOLLOWING THE HEALTH CONDICION OF VOLUNTARY REPEATED BLOOD DONORS IN WU TRANSFUSIOLOGY – GENERAL HOSPITAL IN STIP

J. Vitlarova, N. Kamcev, B. Cuckova, V. Dejanova (WU Trasfusiology; General Hospital-Stip,, Stip, Macedonia)

P-073 COMPARATIVE STUDY OF HAEMOGLOBIN LEVELS IN PREDONATION TESTING

A. Vourtsi, I. Dendrinou, K. Farmaki, A. Markelos, Ch. Pappa, M. Savvanos, I. Tzoumari (Blood Transfusion Service, Corinth, Greece)

Poster Session Topic 2.2:

Donors and Donation - Rare donor programmes

P-074 THE STRATEGY FOLLOWED TO GET A REGISTRY OF ABSOLUTE IGA DEFICIENT BLOOD DONORS IN A COMMUNITY BLOOD CENTRE

M. Adelantado, M. Abalo, C. Areal, A. Castrillo, A. Castro, A. Eiras, J. Cid, J. Flores, J. Cabrera, J. Mauri (Centro de Transfusion de Galicia, A Coruña, Spain)

P-075 AMERINDIAN HLA ALLELES AND BLOOD TRANSFUSIONS

A. Arnaiz-Villena, J.I. Serrano-Vela, R. Reguera, J. Moscoso (The Madrid Regional Transfusion Center, Madrid, Spain)

P-076 DOUBLE RED CELL COLLECTION USING ALYX; SINGLE CENTER EXPERIENCE

D.G. Güven, O.A. Arslan (Ankara University, Faculty of Medicine, Ankara, Turkey)

P-077 MGUS AND BLOD DONATION

M.S. Raffaelli, A. Masci, E. Porta, G. Lepri, F. Tonelli, C. Giacomelli, R. Vannucchi, A. Moretti (Blood Transfusional Center, Viareggio, Italy)

P-078 BLOOD GROUP PHENOTYPE PREDICTION BY MULTIPLEX PCR AND POOLED CAPILLARY ELECTROPHORESIS

F. Wagner, A. Döscher, R. Bittner, E. Petershofen, T. Müller (DRK Blutspendedienst NSTOB, Springe, Germany)

Poster Session Topic 3.1:

Haemapheresis - Donors

P-079 MNC PROCEDURES FOR DLI IN UNRELATED BLOODBANK DONORS

E.A.M. Beckers, F. De Winter, E. Van 't Ende (Sanquin Blood Bank SW, Rotterdam, The Netherlands)

P-080 VISTA INFORMATION SYSTEM CONTRIBUTES TO LEAN MANUFACTURING

M. Cardenas, W. Reed, N. Kalmin, P. James (South Texas Blood and Tissue Center, San Antonio, Texas, United States of America)

P-081 RECRUITMENT PROGRAM FOR RED BLOOD CELL APHAERESIS DONORS

C. Areal, M. Abalo, A. Castrillo, A. Castro, J. Florez, M. Adelántado, J. Cid, A. Eiras, J. Cabrera (Blood Transfusion Center of Galicia, Santiago De Compostella, Spain)

P-082 IRON METABOLISM IN TWO RED CELL UNIT DONORS

D. Clavijo, C. Clavijo, J.E. Soriano, P. Juliá, R. Beneit, C. Gisbert, L. Hernandez, A. Tascon, R. Roig (CTA, San Juan De Alicante, Spain)

P-083 EVALUATION OF THE ALYX SYSTEM FOR THE COLLECTION OF ONE UNIT OF LEUKOREDUCED RBCS AND A CONCURRENT PLASMA PRODUCT

F. Colvin (LifeShare Blood Centers, Shreveport, La, United States of America)

P-084 COMPONENT COLLECTION BY DONATION APHERESIS PORTO REGIONAL BLOOD CENTRE (CRSP)

M.L. Dobao, O. Alves, S. Maia (Instituto Português do Sangue, Porto, Portugal)

P-085 DOUBLE RED BLOOD CELL CONCENTRATE APHERESIS (DRBC) AND CONCURRENT PLATELET-RBC APHERESIS (P-RBC): AN ECONOMICAL STUDY

G. Follea, L. Deslande, C. Adjou (Etablissement Français du Sang PL, Nantes, France)

P-086 INADEQUATE VENOUS APPROACH – THE MOST FREQUENT REASON OF THE DEFERRAL OF DONORS IN THE PROGRAM OF PLATELET APHERESIS AT THE BLOOD TRANSFUSION INSTITUTE OF SERBIA

G.Z. Garic, B.G. Bogdanovic, V.N. Vavic, S.V. Srejic, C.K.M. Cankovic Kadijevic (Blood Transfusion Institute of Serbia, Belgrade, Serbia)

P-087 PREAMTURE TERMINATIONS OF PLATELET APHERESIS PROCUDURES IN TWO DIFFERENT APHERESIS SYSTEMS

H.G. Heuft, L. Goudeva, M. Martens, A. Schmitt-Thomssen, R. Blasczyk (Hannover Medical School, Hannover, Germany)

P-088 COMPARISON OF APHERESIS PLATELETS REDUCED USING AUTOMATED BLOOD CELL SEPARATORS

R. Kongruksa, S. Nathalang, S. Sombatnimitsakul, P. Kupatawintu, O. Nathalang (Thai Red Cross Society, Bangkok, Thailand)

P-089 GRANULOCYTE COLLECTIONS WITHOUT SEDIMENTING AGENTS FOR PATIENTS WITH SEVERE FEBRILE NEUTROPENIA

M. Maresca, R. Putzulu, M. Bianchi, I. Rago, N. Piccirillo, F. Sorà, S. Sica, G. D'Onofrio, G. Leone (Catholic University of Sacred Heart, Rome, Italy)

P-090 PH EVALUATION HAS A POOR USEFULNESS AS QUALITY CONTROL FOR PLATELET-APHERESIS

S. Misso, B. Feola, L. Paesano, E. D'Agostino, M. D'Onofrio, G. Fratellanza, M. Nigro, A. Minerva (Hospital "S. Anna and S. Sebastiano", Caserta, Italy)

P-091 COLLECTION OF PERIPHERAL BLOOD PROGENITOR CELLS (PBPC) WITH LARGE VOLUME LEUKAPHERESIS (LVL) IN 65 HEALTHY DONORS FOR HEMATOPOIETIC ALLOGENEIC TRANSPLANTATION: EXPERIENCE FROM A SINGLE CENTRE.

M.E.M.B. Moreno-Beltran, B.N. Navas, B. Aguado, B. Iñigo, C. Cámara, L. Cano, J. García-Alfaro, A. Alegre, R. Rodríguez-Notario, M.J. Fernandez-Villalta, J.M. Fernandez-Rañada (Hospital Universitario de la Princesa, Madrid, Spain)

P-092 COMPARATIVE STUDY OF TWO DOUBLE RED CELL COLLECTION SYSTEMS

F.S. Schooneman, D.A. Aguettaz, J.J.H. Huart (EFS Nord de France, Lille Cédex, France)

P-093 FERRITIN LEVEL, AS A CRITICAL MARKER OF DONOR SUITABILITY AND SAFETY, IN THREE 2-RBCA DONORS’ POPULATIONS: LISBON RBC EXPERIENCE

A.P. Sousa, E. Canais, J. Seghatchian, G. Sousa (Centro Regional de Sangue de Lisboa, Lisboa, Portugal)

P-094 HIGH T-CELL ACTIVATION IN DONORS’ PERIPHERAL BLOOD LEADS TO ELEVATED LEUKOCYTE CONTAMINATION IN THEIR APHERESIS PLATELET CONCENTRATES

G. Stiegler, K. Jünger, G. Leitner, P. Höcker (Medical University Vienna, Wien, Austria)

P-095 COMPARISON OF AMICUS AND MCS+ FOR DOUBLE DOSE PLATELET COLLECTIONS

C.V. Vale, M.A.M. Madueno, P.M. Marques, I.B. Branco, M.H.M.S. Silva, D.B. Brilhante (I.P.O., Lisboa, Portugal)

P-096 HOW IMPORTANT IS THE AC:WB RATIO IN APHERESIS?

H. Vrielink, P.F. Van der Meer, M.M.W. Koopman, R.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, The Netherlands)

P-097 ADVERSE REACTIONS IN APHERESIS DONORS

K. Ziciadis, F. Karabini, E. Xanthi, A. Tzolou, E. Zervou (University Hospital of Ioannina, Ioannina, Greece)

Poster Session Topic 3.2:

Haemapheresis - Therapeutic

P-098 THE USE OF AMICUS SEPARATOR IN A NON-STANDARD PROTOCOL

I.B. Branco, D.B. Brilhante, G.S. Salta (IPOFG-CROL, EPE, Lisboa, Portugal)

P-099 PLASMAPHERESIS IN ACUTE HUMORAL REJECTION AFTER KIDNEY TRANSPLANTATION

J.M. García Gala, J. Baltar Martin, P. Rodriguez Vicente, F. Ortega Suarez, C. Morante Pombo, C. Corte Diaz (Hospital Universitario Central de Asturi, Oviedo, Spain)

P-100 ERYTHROCYTAPHERESIS VERSUS THERAPEUTIC PHLEBOTOMY FOR THE TREATMENT OF THE HEREDITARY HAEMOCHROMATOSIS

M. Mottola, G. Di Domenico, G.M. Leonardi, A. Della Corte, F. Varricchio, D. Meomartini, L. Maisto, E. Santoro (Immunohematology service, S.Giovanni Bos, Napoli, Italy)

P-101 THERAPEUTIC ERYTHROCYTAPHERESIS - RESULTS OF 10 YEARS EXPERIENCE WITH HAEMONETICS

L. Pagacova, P. Pajtasova, A. Bartu, J. Charvat (Institute of Clin.and Experiment. Med., Prague, Czech Republic)

P-102 THERAPEUTIC LEUKOCYTAPHERESIS AND THROMBOCYTAPHERESIS WITH HAEMONETICS MCS+

L. Pagacova, V. Antosova (Institute of Clin. and Experiment. Med., Prague, Czech Republic)

P-103 CELL COLLECTION FOR EXTRACORPOREAL PHOTOCHEMOTHERAPY USING THREE DIFFFERENT CELL SEPARATORS

N. Piccirillo, F. Sorà, M. Maresca, R. Putzulu, M. Bianchi, I. Rago, P. Chiusolo, S. Sica, G. D'Onofrio, G. Leone (Catholic University of Sacred Heart, Rome, Italy)

P-104 IMMUNOADSORPTION AND PLASMAPHERESIS SHOW POSITIVE EFFECT AFTER KIDNEY TRANSPLANTATION

S. Rummler, K. Althaus, U. Ott, J. Gerth, G. Wolf, D. Barz (Universitätsklinikum Jena, Jena, Germany)

P-105 KINETICS OF IRON MOBILIZATION IN THE TREATMENT OF HEREDITARY HEMOCHROMATOSIS (HH)

C. Sanz, A. García, A. Pereira (Hospital Clinic, Barcelona, Spain)

P-106 SAFETY AND EFFECTIVENESS OF LEUKAPHERESIS IN PATIENTS WITH ACUTE HYPERLEUKOCYTIC LEUKAEMIA

F. Sorà, M. Bianchi, N. Piccirillo, M. Maresca, R. Putzulu, I. Rago, L. Laurenti, S. Sica, G. D'Onofrio, G. Leone (Catholic University of Sacred Heart, Rome, Italy)

P-107 THERAPEUTIC PLASMA EXCHANGE IN THE PATIENT SUFFERING FROM MYASTHENIA GRAVIS

S.V. Srejic, B.G. Bogdanovic, A.S. Apostolski, G.Z. Garic, C.K.M. Cankovic Kadijevic (Blood Transfusion Institute of Serbia, Belgrade, Serbia)

P-108 ERYTHROCITAPHERESIS IN HEREDITARY HEMOCHROMATOSIS OF RECENT DIAGNOSIS

M.M. Trujillo, A. Carrero, P. Luque (Blood Transfusion Center, Jaen, Spain)

P-109 MONOCYTE APHERESIS WITH 225 ML LATHAM BOWL (MCS)

H. Vrielink, P.F. Van der Meer, M.M.W. Koopman, R.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, The Netherlands)

P-110 TREATMENT OF MYASTHENIA GRAVIS WITH PROTEIN - A IMMUNOADSORPTION: A CASE REPORT

K. Zeliszewska, Z. Gasova, M. Bohmova (Institute of Hematology and Blood Transf, Prague, Czech Republic)

Poster Session Topic 3.3:

Haemapheresis - Thrombotic Thrombcytopaenic Pupura (TTP)

P-111 MANAGING OF PLASMA TREATMENT IN PATIENTS WITH RELAPSED FORM OF TTP

Z. Cermakova, J. Furkova, R. Hrdlickova, M. Koristka (Faculty Hospital, Ostrava, Czech Republic)

P-112 TTP THERAPY IN A BLOOD BANK SETTING: A 20 YEAR OVERVIEW (1987-2007)

G. Kanellopoulou, K. Markakis, P. Kotsi, A. Marinaki, A. Karafoulidou (Laikon General Hospital, Athens, Greece)

P-113 THROMBOTIC THROMBOCYTOPAENIC PURPURA. CASE REPORT OF A PATIENT ON LONG-TERM THERAPY

M. Mottola, G. Di Domenico, G.M. Leonardi, A. Della Corte, F. Varricchio, G. Vaccaro, E. Santoro (Immunohematology service, S.Giovanni Bos, Napoli, Italy)

P-114 BENEFICIAL EFFECTS OF EARLY ADJUNCTIVE TREATMENT USING RITUXIMAB DURING ACUTE REFRACTORY TTP

P. Poullin, G. Kaplanski, N. Schleinitz, K. Mazodier, H. Chambost, J.M. Durand, J.R. Harle, P.A. Lefevre (University Hospital La Conception, Marseille, France)

Poster Session Topic 4.0:

Blood Processing

P-115 EVALUATION OF COMPUTERIZED ON-LINE DONOR PROCESSING SYSTEM ON ERROR, DEFERRAL RATE AND DONOR SATISFACTION IN ESFAHAN, 2005

M. Aghahosaini, A. Shaemi, K. Azarbiejani, N. Akbari Dorcheh (Iranian Blood Transfusion Organization, Esfahan, Iran)

P-116 IMPROVEMENT OF HB-CONTENT BY A NEW FILTER FOR RBC LEUKOREDUCTION

A. Agildere, E. Richter (Red Cross Blood Transfusion Service, Baden-Baden, Germany)

P-117 QUALITY CONTROL ON BLOOD COMPONENTS PREPARATION LAB IN CENTRAL BLOOD BANK IN KUWAIT DURING 2005

M. Al Quallaf, K. Al Yhagot (Central Blood Bank, Kuwait, Kuwait)

P-118 ETHICS IN TRANSFUSION MEDICINE

A.M. Andjelic (Blood Transfusion Institute of Serbia, Belgrade, Serbia)

P-119 POOLED PLATELET CONCENTRATES OBTAINED WITH AUTOMATED METHOD

J. Antoniewicz-Papis, A. Goller, E. Lachert, A. Rosiek, J. Kubis, D. Piotrowski, M. Letowska (Inst. of Haemat. and Transf. Med., Warsaw, Poland)

P-120 COMPARISON OF IN VITRO PARAMETERS FROZEN RBCS, LEUKO AND NON-LEUKODEPLETED, COLLECTED BY APHERESIS OR FROM WHOLE BLOOD, STORED FOR 21 DAYS AFTER DEGLYCEROLIZATION AND RESUSPENSION IN AS-3 (NUTRICEL).

M.B. Bohonek, M. Petras, I. Turek, T. Hradek, J. Urbanova, V. Staroprazska, J. Kostirova, S. Duchkova, D. Horcickova (Central Military Hospital Prague, Prague, Czech Republic)

P-121 STATISTICAL PROCESS CONTROL OF THE HEMOGLOBIN CONTENT OF BUFFY-COAT REMOVED, LEUKODEPLETED RED CELL CONCENTRATES

V. Bosnes, F. Ezligini, K.R. Eriksen (Ulleval University Hospital, Oslo, Norway)

P-122 EVALUATION OF BLOOD COMPONENTS COLLECTED BY ABC® SYSTEM

A Castrillo, C. Areal, M. Abalo, M. Adelantado, A. Castro, J. Cid, A. Eiras, J. Flores, J. Cabrera (Galician Transfusion Center, Santiago De Compostela, Spain)

P-123 BLOOD COMPONENT PREPARATION WITH THE ATREUS 2C+ SYSTEM IN ROUTINE USE

J. Cid, M. Claparols, A. Pinacho, P. Ortiz, L. Puig, R.P. Pla (Banc de Sang i Teixits, Barcelona, Spain)

P-124 PLATELET CONCENTRATES IN PH READING CONTAINERS

M.J. Dijkstra-Tiekstra, A.C. Setroikromo, L. Scholten-Pijper, C.J. van Delden, J. de Wildt-Eggen (Sanquin Blood Bank North East Region, Groningen, The Netherlands)

P-125 DESIGN OF A NEW LINER IN IRANIAN BLOOD TRANSFUSION ORGANISATION(IBTO) TO PREVENT FOLDING OF BLOOD BAGS WHILE CENTRIFUGING

M. Fallah Tafti, S. Zolfaghari, A. Talebian, M. Moghadam, M. Ahmadinejad, F. Kami, F. Asgharipour (IBTO, Tehran, Iran)

P-126 ERGONOMICS OF A NEW AUTOMATED CENTRIFUGATION/SEPARATION METHOD COMPARED TO A CONVENTIONAL BOTTOM-AND-TOP SYSTEM

J. Georgsen, S. Mayland, B. Damm, T.B. Hinrichsen, L. Albjerg, K. Titlestad (Funen Transfusion Service, Odense C, Denmark)

P-127 USE OF ADDITIVE SOLUTION FOR 10 DAY STORAGE OF PLATELET CONCENTRATES

A. Goller, J. Antoniewicz-Papis, E. Lachert, J. Kubis, M. Zaleska, R. Palka, M. Letowska (Inst. of Haemat. and Transf. Med., Warsaw, Poland)

P-128 PLATELET CONCENTRATES OBTAINED IN A BLOOD CENTRE: A TWO YEAR ANALYSIS

M.I. González Fraile, M. Yañez Izquierdo, M.A. Moya San Pedro, V.F. Padron Rivas (Centro de Hemoterapia de Castilla y León, Valladolid, Spain)

P-129 DEVELOPMENT OF A LEUKO-REDUCING BOWL FOR AN INTERMITTENT PLATELETPHERESIS

S.I. Inaba, K.S. Sakota (Kanagawa Red Cross Blood Center, Yokohama, Japan)

P-130 VALIDATION OF THE NEW TERUMO ADVANCED COMPONENT CENTRIFUGE WITH SEPARATOR INTEGRATED OF PLATELETS CONCENTRATES FROM BC

M.J. Jurado, C. Arquero, I. Garcia, I. Amigo, C. Romero, L. Garcia, M. Lopez, P. Fernandez, V. Fernandez, L. Barbolla (Centro de Transfusión de Madrid, Madrid, Spain)

P-131 INITIAL INTRACELLULAR PH DETERMINES MAINTENANCE OF 2,3-DPG DURING STORAGE OF RED CELL CONCENTRATES

D. de Korte, H.G.H. Korsten, M. Kleine, A.J. Verhoeven (Sanquin Research, Amsterdam, The Netherlands)

P-132 STORAGE-DEPENDENT REMODELING OF THE RBC MEMBRANE IS ASSOCIATED WITH INCREASED IGG BINDING, LIPID RAFT REARRANGEMENT AND CASPASE ACTIVATION

A. Kriebardis, M. Antonelou, K. Stamoulis, E. Economou-Petersen, L. Margaritis, I. Papasideri (University of Athens, Athens, Greece)

P-133 EVALUATION OF LEUKODEPLETED PLATELET CONCENTRATES AFTER 10 DAY STORAGE IN ADDITIVE SOLUTION (SSP+, MACOPHARMA)

E. Lachert, J. Kubis, J. Antoniewicz-Papis, A. Goller, K. Bykowska, G. Kula, B. Biedrzycka, M. Letowska (Inst. of Haemat. and Transf.Med., Warsaw, Poland)

P-134 PLATELET COUNT FROM PLATELET CONCENTRATES AT DIFFERENT DILUTIONS ¿IS THERE A DIFFERENCE?

L. Larrea, M.I. Ortiz de Salazar, T. Pamplona, V. Mirabet, P. Solves, M.A. Soler, R. Roig (Centro Transfusion Comunidad Valencia, Valencia, Spain)

P-135 EFFECT OF THE INTRODUCTION OF A NEW EXPANDER IN THE IN-LINE FILTER FOR RED CELL CONCENTRATES

L. Larrea, P. Solves, V. Mirabet, M.A. Soler, R. Roig (Centro Transfusion Comunidad Valencia, Valencia, Spain)

P-136 QUALITY CONTROL IN RED CELL CONCENTRATES AFTER LEAVING A 'DRY' BUFFY-COAT

L. Larrea, T. Pamplona, M.I. Ortiz de Salazar, V. Mirabet, P. Solves, M.A. Soler, R. Roig (Centro Transfusion Comunidad Valencia, Valencia, Spain)

P-137 BLOOD STORED: STUDY OF ERYTHROCYTAIRE CHARGE SURFACE PROPERTIES

N. Lebensohn, M. D'Arrigo, P. Foresto, J. Valverde (Fac. Cs. Bioquímias y Farmacéuticas -UNR, Rosario, Argentina)

P-138 QUALITY CONTROL OF PLATELET CONCENTRATES - OUR EXPERIENCES

L. Lokar, L. Lokar, V. Urlep S˜ alinovic (Maribor Teaching Hospital, Maribor, Slovenia)

P-139 AUTOMATIC PLATELET PROCESSING (ORBISAC) PORTO REGIONAL BLOOD CENTRE

S. Maia (Instituto Português do Sangue, Porto, Portugal)

P-140 IMPROVED PRODUCTION PROCESS MANAGEMENT (ATREUS/ORBISAC) PORTO REGIONAL BLOOD CENTRE (CRSP)

S. Maia (Instituto Português do Sangue, Porto, Portugal)

P-141 AUTOMATIC WHOLE BLOOD PROCESSING (ATREUS) PORTO REGIONAL BLOOD CENTRE

S. Maia (Instituto Português do Sangue, Porto, Portugal)

P-142 COMPARISON OF PLATELET CONCENTRATES STORED IN PLASMA OR IN 3 DIFFERENT ADDITIVE SOLUTIONS

P.F. van der Meer, I.J. Bontekoe, R.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, The Netherlands)

P-143 STORAGE OF LEUKOREDUCED RED CELL CONCENTRATES IN PLASTIC OVERWRAPS

P.F. van der Meer, M. Eijzenga, R.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, The Netherlands)

P-144 COMPARATIVE ANALYSIS OF PLATELET UNITS PREPARED IN 2005 AND 2006

M.S. Mijovic, A.M. Andjelic, A.M. Antic (Blood Transfusion Institute of Serbia, Belgrade, Serbia)

P-145 QUALITY ANALYSIS ON FRACTIONATED PLATELET CONCENTRATES STORED FOR 5 DAYS IN A HALVED VOLUME OF PLASMA

S. Misso, B. Feola, L. Paesano, M. D'Onofrio, G. Fratellanza, E. D'Agostino, S. Marotta, R. Sepulveres, M. Nigro, A. Minerva (Hospital "S. Anna and S. Sebastiano", Caserta, Italy)

P-146 THE VOLUME OF STORED PLATELET CONCENTRATES CAN BE REDUCED IN A MANNER WHICH MAINTAINS PLATELET PROPERTIES

S. Misso, B. Feola, L. Paesano, M. D'Onofrio, G. Fratellanza, E. D'Agostino, A. D'Ambra, R. Sepulveres, M. Nigro, A. Minerva (Hospital "S. Anna and S. Sebastiano", Caserta, Italy)

P-147 IMMATURE PLATELET FRACTION (IPF) AND ITS VALUE TO DETERMINE THROMBOPOIESIS STATUS. PRELIMINARY DATA

M. Molero, A. Lemes, J. López, P. Martín, S. De la Iglesia, R. Martín, G. García, S. Jiménez (Hospital Universitario de Gran Canaria, Las Palmas De Gran Canaria, Spain)

P-148 NEW AUTOMATED APHERESIS SYSTEM FOR LEUKOREDUCED DOUBLE-DOSE RED CELL COLLECTION WITH ADVANTAGES OF REDUCED EXTRACORPOREAL VOLUME AND TRUE MOBILITY

N.W. Nussbaumer, Ch. Grabmer, C. Bader, W. Mayer, O. Nussbaumer, E.M. Amann, H. Schennach (Univ.Hospital Innsbruck, Innsbruck, Austria)

P-149 COMPARISON OF BLOOD COMPONENT PREPARATION METHOD OF WHOLE BLOOD BAGS BASED ON BUFFY COAT EXTRACTION

M. Pinacho, J. Cid, J.M. Sanchez, M. Panadés, P. Ortiz, R.P. Pla, M. Claparols, L.l. Puig (Banc de Sang i Teixits, Lleida, Spain)

P-150 EVALUATION OF LEUKOCYTES SUBPOPULATION IN WHOLE BLOOD BEFORE AND AFTER PRESTORAGE FILTRATION

A. Pourfathollah, H. Razi, M. Nikokoftar, M. Aghaeipour (Tarbiat Modares University, Tehran, Iran)

P-151 MINIMAL RESIDUAL DISEASE IN THE APHERESIS PRODUCTS FROM PATIENTS WITH MULTIPLE MYELOMA

M. Subirá, C. Serrano, E. Askari, A. Román, A. De la Fuente, M. Callejas, M. Díaz-Morfa, S. Castañón, R. Gonzalo, J.L. López Lorenzo, C. Paniagua, P. LLamas (Fundación Jiménez Díaz, Madrid, Spain)

P-152 L-CARNITINE REDUCES GLYCOLYSIS AND MAINTAINS PH TO DAY 7 IN HYPERCONCENTRATED PLATELET POOLS

D. Sweeney, D. Sweeney, A. Arduini, H. Holme (Lifespan, Providence, United States of America)

P-153 ORBISAC BC SYSTEM: AN AUTOMATED SYSTEM THAT ALLOWS THE OPTIMISATION AND STANDARDISATION OF THE PRODUCTION OF POOLED PLATELET CONCENTRATES

R. Tardivel, S. Bois, D. Massot, G. Semana (EFS-Bretagne-Rennes, Rennes, France)

P-154 PERFORMANCES OF AN UPDATED SOFT-SHELL FILTER FOR LEUKOREDUCTION OF RED CELL CONCENTRATES

N. de Valensart, R. Demeuter, A. Rapaille (Belgian Red Cross, Liège, Belgium)

P-155 IMPLEMENTATION OF THE AUTOMATED ORBISAC' BC SYSTEM TO PREPARE WHOLE BLOOD DERIVED PLATELET CONCENTRATES AT THE EFS ALPES MEDITERRANEE BLOOD CENTER

C. Vignoli, F. Donnadieu, G. Difede, R. Iapicco, J. Chiaroni, P. De Micco (Etablissement Français du Sang, Marseille, France)

P-156 CRYOPRESERVED VS. LIQUID STORED PLATELETS - FROM THE BASIC TO THE UP TO DATE FINDINGS

D. Vucetic, B. Balint, D. Vojvodic, S. Mandic-Radic, V. Subota, M. Trkuljic (Institute of Transfusiology, VMA, Belgrade, Serbia)

P-158 RED BLOOD CELLS: QUALITY CONTROL IN A BLOOD CENTRE: TWO YEAR SURVEY

M. Yañez Izquierdo, M.I. Gonzalez Fraile, M.A. Moya San Pedro, F.V. Padron Rivas (Centro de Hemoterapia de Castilla y Leon, Valladolid, Spain)

Poster Session Topic- 5.0

Plasma Derivatives and Fractionation

P-159 HUMAN PLASMA FRACTIONATION PROGRAM: ANALYSIS FROM 2001-2006

M. Calabuig, L. Larrera, J. Belmar, R. Roig (Transfusion Blood Center of Valencia, Valencia, Spain)

P-161 AN ECONOMICAL PROCESS FOR PRODUCTION OF HUMAN SERUM ALBUMIN 20%

M. Jalili, H. Khorsand (Research Center of Blood Transfusion Org, Tehran, Iran)

P-162 WHY SHOULD TURKEY HAVE A PLASMAFRACTIONATION INDUSTRY?

N. Solaz (Ankara University, Ankara, Turkey)

P-163 STUDY ABOUT THE CAUSES OF DESTRUCTION OF PLASMA

A. Toril Diaz, T. Arroyo Zabas, J.M. Brull Sabaté (Blood Bank of Extremadura, Mérida, Spain)

P-164 LOOK BACK STUDY ON IRANIAN SEROCONVERTED DONORS THAT THEIR PLASMA SENT FOR FRACTIONATION

S.Z Zolfaghari Anaraki, A. Talebian, S. Sedaghat, N. Hassan Pour (Iranian Blood Transfusion Organization, Tehran, Iran)

Poster Session Topic 6.0:

Blood Safety-Transfusion Transmitted Disease

P-165 THE PREVALENCE OF HTLV I - II IN BLOOD DONORS IN A TRANSFUSION DEPARTMENT OF CRETE

I. Bolonaki, I. Nikoloudi, E. Lydaki, M. Vazakopoulou, K. Foundouli (University Hospital of Heraklion Crete, Heraklion Crete, Greece)

P-166 VALIDATION OF THE ABBOTT ARCHITECT SYPHILIS TP ASSAY FOR DONORS SPECIMENS

M.E. Maria Elena, P. Ezpeleta, A.M. Piedrabuenas, M. Fuentes, M.A. Jurado, J. Ruiz de la Hermosa, M.L. Cieza, R. Olmos (Complejo Hospitalario de Ciudad Real, Ciudad Real, Spain)

Poster Session Topic 6.1:

Blood Safety - Transfusion Transmitted Disease (TTD) - HIV

P-167 CONFIDENTIAL UNIT EXCLUSION PROCESS AND BLOOD SAFETY; THE IRANIAN BLOOD TRANSFUSION ORGANIZATION EXPERIENCE BETWEEN MARCH 2004 AND SEPTEMBER 2006

S. Amini Kafi-Abad, M. Shariati, M. Moghaddam, A. Talebian (Research center-Iranian Blood Transfusio, Tehran, Iran)

P-168 SEROEPIDEMIOLOGICAL DATA OF HIV INFECTION IN BLOOD DONORS IN TIRANA

V. Durro, Zh. Abazaj, I. Seferi (NBTSA, Tirana, Albania)

P-169 EVALUATION OF THE ABBOTT PRISM HIV COMBINED ANTIBODY/ANTIGEN-ASSAY

M.K. Hourfar, G. Geusendam, A. Vosberg, T. Dengler, K. Frank, A. Karl, M. Löhr, W. Sireis, E. Seifried, M. Schmidt (German Red Cross, Frankfurt, Germany)

P-170 THE OUTBREAK OF TRANSFUSION-TRANSMITTED HTLV INFECTION BY ONE BLOOD DONOR WITH HTLV IN KOREA

T.Y. Kim (Center for disease control & prevention, Seoul, South-Korea)

XXVII TH REGIONAL CONGRESS OF THE ISBT, EUROPE INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION

P-171 LONG-TERM ABNORMALITIES OF OF COMPLETE BLOOD COUNTS IN HUMAN T-LYMPHOTROPIC VIRUS TYPES I AND II (HTLV-I AND -II) INFECTION

L. Murphy, A.. Yeo, Z. Kaidarova, J. Gibble, J.W. Smith, B. Newman, G. Garratty, J. Fridey, R. Sacher (UCSF and BSRI, San Francisco, Ca, United States of America)

P-172 ROLE OF INDONESIAN RED CROSS (IRC) IN REDUCING HIV TRANSMISSION THROUGH LINKED CONFIDENTIAL POLICY IN BLOOD TRANSFUSION SERVICE (BTS) : YOGYAKARTA CASE

R. Nur Aditya (Indonesian Red Cross, Jakarta, Indonesia)

P-174 IDENTIFICATION OF HIV TRANSMISSION BY TRANSFUSION: SOUTH KOREA’S HIV LOOKBACK INVESTIGATION

J.Y. Shin, M.S. Park, C.H. Kim (KCDC, Seoul, South-Korea)

P-175 PRISM® HIV ANTIGEN-ANTIBODY COMBINATION ASSAY FOR BLOOD DONOR SCREENING

E. Sickinger, N. Schuster, L. Kintscher, A. Goller, M. Hausmann, H.P. Kapprell (Abbott GmbH & Co. KG, Wiesbaden-delkenheim, Germany)

P-176 EVALUATION OF SENSITIVITY AND SPECIFICITY OF ABBOTT ARCHITECT® HIV AG/AB COMBO ASSAY USING SEROCONVERSION PANELS, HIV TYPE / SUBTYPE SPECIMENS AND JAPANESE HOSPITALIZED SAMPLES

S. Takeda (Asahikawa Medical College Hospital, Asahikawa, Japan)

P-177 EVALUATION OF A HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN-ANTIBODY SCREENING ASSAY AFTER SOFTWARE UPGRADE

M. Zaccarin, A.M. Ovesen, B.K. Møller, N. Grunnet (Aarhus University Hospital, Aarhus N, Denmark)

P-178 LYMPHOCYTE SUBSETS EVALUATION IN IRANIAN HIV NEGATIVE PATIENTS WITH IMMUNODEFICIENCY FEATURES REFFERED TO IRANIAN BLOOD TRANSFUSION RESEARCH CENTER

M. Aghaeipour, A. Talebian, M. Nikogooftar (Iranian Blood Transfusion Research Cente, Tehran, Iran)

Poster Session Topic 6.2:

Blood Safety - Transfusion Transmitted Disease (TTD) - Hepatitis

P-179 THE STRATEGY FOR ELIMINATING HBV. TRANSMISSION THROUGH BLOOD TRANSFUSION IN UNITED ARAB EMIRATES

A. Alamiri (Ministry of Health, Sharjah, United Arab Emirates)

P-180 PREVALENCE OF HEPATITIS G VIRUS AMONG IRNIAN BLOOD DONORS BY POLYMERASE CHAIN REACTION METHOD

S. Amini Kafi-Abad, F. Ranjbar Kermani, Sh. Samiei, M. Moghtadaiei, F. Ferdosian, Z. Ataiei, M. Kavari, N. Pasandideh, A. Gharabaghian, A. Talebian (Research Center-Iranian Blood Transfusio, Tehran, Iran)

P-181 THE PRESENCE OF THE HBSAG POSITIVE BLOOD DONORS DURING THE 2006 IN REPUBLIC OF MACEDONIA

A.G. Andonov, G.A. Goran, R.K. Kalamaras, M.B. Blagoevska, E.K. Edrovska-Isajlovska, T.M. Makarovska-Bojadzieva, S.T. Trajkovska, S.S. Stojkoska (National Institute for Blood Transfusion, Skopje, Macedonia)

P-182 HBV-DNA INVESTIGATION BY REAL-TIME PCR METHOD IN ISOLATED ANTI-HBC POSITIVE CASES AND IMPOTANCE OF THESE CASES IN BLOOD BANKING

S.H. Bal, Y. Heper, L.T. Kumas, O. Tore (Uludag University Faculty of Medicine, Bursa, Turkey)

P-183 CELLULAR HCV-SPECIFIC IMMUNE RESPONSE AMONG RIBA-3 INDETERMINATE BLOOD DONORS: A CONFIRMATORY EVIDENCE OF HCV EXPOSURE

M. Bes, J.I. Esteban, N. Casamitjana, M. Piron, J. Quer, L.l. Puig, S. Sauleda (Banc de Sang i Teixits, Barcelona, Spain)

P-184 SERUM PREVALENCE OF MARKERS OF HEPATITIS B AND MANAGEMENT OF BLOOD DONORS IN A TRANSFUSION DEPARTMENT

I. Bolonaki, I. Nikoloudi, E. Lydaki, A. Pagalaki, K. Foundouli (University Hospital of Heraklion Crete, Heraklion Crete, Greece)

P-185 HEPATITIS C VIRUS GENOTYPE PREVALENCE AMONG BLOOD DONORS FROM CENTRAL PORTUGAL

M.R. Caldeira, M.J.N. Teixeira, F.J.F.C. Henggeler, N.F. Mateus, R.C.A. Diniz, M.H. Gonçalves (Portuguese Blood Institute, Coimbra, Portugal)

P-186 HUMAN HERPESVIRUS 8 (HHV-8) SEROPREVALENCE IN BLOOD DONORS FROM RIO DE JANEIRO, BRAZIL

S. de Carvalho, S. Dias, N. Leite, E. Silva, L. Jesus, M. Rios, S. Lee, I. Hewlett (Inst. Estadual de Hematologia - HEMORIO, Rio De Janeiro, Brazil)

P-187 EPIDEMIOLOGIC CHARACTERISTICS OF HBSAG (+) GREEK BLOOD DONORS IN A REGIONAL BLOOD TRANSFUSION CENTER (1999-2006)

M. Chatzitaki, E. Diamanti, N. Staboulzis, V. Dafou, E. Gramoustianou, E. Xiromeritis (General Hospital of Larissa, Larissa, Greece)

P-188 SEROLOGIC MARKERS FOR HEPATITIS B IN BLOOD DONORS: PROFILE OF ANTI- HBCORE REACTIVE

A.O. Chiera, C. Bonacina, G. Larrañaga, N. Etchenique (Hemotherapy Institute of Buenos Aires Pr, La Plata, Argentina)

P-189 IRON DEPLETION IN PATIENTS AFFECTED WITH CHRONIC HEPATITIS HCV-RELATED AND SECONDARY HEMOSIDEROSIS HAVE NOT BENEFICAL EFFECTS ON VIRAL REPLICATION

M. D'Onofrio, L. Paesano, I. Gentile, C. Viola, E. D'Agostino, E. Perna, M. Piazza, G. Borgia, S. Formisano (PO "San Giovanni Bosco" ASL NA1, Naples, Italy)

P-190 HBV MUTATIONS IN PRECORE/CORE REGION IN A GROUP OF CHRONIC HEPATITIS B PATIENTS: PILOT STUDY

V. Drazic, I. Babic, J. Bingulac-Popovic, I. Mihaljevic, M. Lovric, M. Balija, I. Jukic (Croatian Institute of Transfusion Medici, Zagreb, Croatia)

P-191 ALAT ACTIVITY TEST - A USEFUL TOOL FOR ELIMINATING VIRAL HEPATITIS CARRIERS FROM DONOR POPULATION?

A. Dzieciatkowska, A. Rosiek, M. Letowska (IHiT, Warsaw, Poland)

P-192 BEHAVIOUR CHANGES AMONG HBS AND HCV POSITIVE DONORS TOWARD BLOOD DONATION, WHO DONATE AGAIN FOLLOWING NOTIFICATION

E. Edrovska, V. Velich Stefanovska, J. Aleksovska, R. Kalamaras (Institute of Blood Transfusion, Skopje, Macedonia)

P-193 EVALUATION ABILITY OF DS-EIA-HBSAG-0.01 ASSAY TO REDUCE SEROCONVERSION WINDOW PERIOD

I. Egorova, Y. Pyrenkova Irina, N. Igolkina Svetlana, N. Sharipova Irina, F. Puzyrev Vladimir, P. Obriadina Anna, N. Burkov Anatoly, I. Ulanova Tatiana (RPC "Diagnostic systems", Nizhniy Novgorod, Russian Federation)

P-194 HIGH LEVELS OF ALANINE AMINOTRANSFERASE AS THE FIRST LABORATORIAL CAUSE OF REJECTED BLOOD DONATION IN THE COIMBRA UNIVERSITY HOSPITAL

J.R. Fernández Menéndez, D. Ferreira, R. Portugal, P. Neto (Coimbra University Hospital, Coimbra, Portugal)

P-195 CHARACTERISATION OF OCCULT HEPATITIS B IN BLOOD DONORS

P. Ghiazza, J.P. Allain, E. Cesale Ros, G. Cornagliotto, G. Demarchi, G. Demarin, V. Gariglio, N. Lelie, R. Marinoni, A. Martinelli, L. Perugini, M. Ricotti, M. Trivè (OIRM - S.Anna Hospital, Torino, Italy)

P-196 IMMUNODISREGULATION IN CHRONIC HEPATITIS C INFECTION: THE MECHANISMS OF AUTOANTIBODY PRODUCTION

H. Gohar, M. Lukic, A. Parkes (Sharjah Blood Transfusion & Research Centre, Sharjah, United Arab Emirates)

P-197 HCV AND HBV INFECTION MARKERS IN YOUNG VS. ADULT HAEMOPHILIA PATIENTS IN POLAND

P. Grabarczyk, J. Windyga, J. Medynska, M. Mikulska, A. Klukowska, E. Stefanska, A. Buczma, A. Szczepanik, E. Brojer (Inst. of Hematology and Transfusion Med., Warsaw, Poland)

P-198 HEPATITIS B VIRUS DETECTION IN POLISH BLOOD DONORS (1994-2004)

P. Grabarczyk, E. Brojer, M. Letowska, M. Mikulska, M. Rosinska, H. Seyfried (Inst. of Hematology and Transfusion Med., Warsaw, Poland)

P-199 PREVALENCE OF HEPATITIS B, C AND HIV MARKERS IN THALASSEMIC AND HAEMOPHILIC PATIENTS IN ESFAHAN, IRAN, 2004

M.M. Hariri, N. Akbari Dorcheh, F. Yavari, E. Javadi, H. Javer (Iranian Blood Transfusion Organization, Esfahan, Iran)

P-200 DETECTION OF HEPATITIS B VIRUS INFECTION IN A POPULATION OF HIV-1 INFECTED INDIVIDUALS IN RURAL ZIMBABWE

L. Harritshoj, C. Erikstrup, P. Kallestrup, R. Zinyama, E. Gomo, J. Gerstoft, H. Ullum (Rigshospitalet, Copenhagen, Denmark)

P-201 ANALYSIS OF THE CELLULAR IMMUNE RESPONSE IN NON VIREMIC BLOOD DONORS WITH ISOLATED ANTI-HCV REACTIVITY

T. Hitziger, M. Schmidt, A. Schumann, V. Schottstedt, H. Hennig, E. Seifried, M. Roggendorf (Institute of Virology, Essen, Germany)

P-203 HEV SCREENING FOR BLOOD DONORS

H. Ikeda, H. Sakata, K. Matsubayashi, E. Tokushima, S. Tanaka, S. Sato, T. Kato (Hokkaido Red Cross Blood Center, Sapporo, Japan)

P-204 PERFORMANCE EVALUATION OF THE NEW ARCHITECT HCV AG/AB COMBO ASSAY FOR BLOOD SCREENING AND DIAGNOSTICS

H.P. Kapprell, R. Gutierrez, T. Leary, C. Pelzer, G. Jonas, M. Roebbecke, M. Hausmann, G. Schochetman, G. Schlauder, G. Dawson (Abbott GmbH & Co.KG, Wiesbaden, Germany)

P-205 IMPLICATION OF OCCULT HBV INFECTION IN TESTS FOR TRANSFUSION-TRANSMITTED VIRAL INFECTION

S. Kino, Y. Tomoda, R. Endo, K. Shibusa, K. Morishita, S. Sato, T. Kato, H. Ikeda (Asahikawa Medical College Hospital, Asahikawa, Japan)

P-206 HEPATITS HCV: THREE DIFFERENT GROUPS OF BLOOD DONORS DURING THE YEARS 2000-2005

A. Kourenti, M. Papakonstantinou, J. Chaniotis, E. Serafi, B. Zevgolis, S. Valsami, T. Chatzis, G. Papadopoulos, X. Lekatsa, S. Stefanakou, K. Stamoulis, V. Fakitsa (District General Hospital of Nikea, Athens, Greece)

P-207 ANTIBODY PERFORMANCE REMAINS ESSENTIAL FOR EARLY DETECTION IN HCV ANTIGEN-ANTIBODY ASSAYS

N. Lambert, V. Prigent, B. Slizewicz, S. Gadelle, A. Sanjuan (Bio-Rad, Marnes-la-coquette, France)

P-208 TRANSFUSION TRANSMITTED HEPATITIS B - CASE REPORT

S. Levicnik-Stezinar, U. Rahne-Potokar (Blood Transfusion Centre of Slovenia, Ljubljana, Slovenia)

P-209 HEPATITIS B VIRAL INFECTION AMONG BLOOD DONORS - WHAT DO WE EXPECT

V. Libek, L. Mijovic Nikolic, A. Strugar, N. Rankovic, A. Kulic (Clinical Hospital Zemun Belgrade, Belgrade, Serbia)

P-210 ACTUAL INCIDENCE OF HBV INFECTIONS IN REPEAT BLOOD DONORS IN NORTH-WEST ITALY: MORE THAN WE THOUGHT

P. Manzini, F. Danielle, C. Balloco, M. Prina, C. Avdis, F. Curti, C. Valpreda (A.O. S. Giovanni Battista di Torino, Torino, Italy)

P-211 EVALUATION OF THE SPECIFICITY OF THE NEW HCV ANTIGEN/ANTIBODY COMBINATION ASSAY

I. Mihaljevic, M. Lovric, M. Berendika, A. Vockel (Croatian Institute of Transfusion Medici, Zagreb, Croatia)

P-212 PROTEOMIC STUDY OF HUMAN PLASMA : IDENTIFICATION OF APOC-III AS A POTENTIAL BIOMARKER ASSOCIATED WITH THE RESOLUTION OF HCV INFECTION

S. Molina, D. Misse, S. Roche, C. Bonfils, S. Badiou, J.P. Cristol, F. Veas, T. Levayer, P. Maurel, J. Coste, C. Fournier-Wirth (Etablissement Français du Sang, Montpellier, France)

P-213 A FULLY AUTOMATED AND HIGHLY SENSITIVE IMMUNOASSAY FOR HEPATITIS C VIRUS (HCV) CORE ANTIGEN

K.X. Morota, R. Fujinami, H. Kinukawa, K. Aoyagi, K. Iida, T. Ishida, N. Matsubara, T. Machida, K. Ohno, H. Saegusa, N. Maki, T. Itoh, K. Takeda (Abbott, Matsudo City, Japan)

P-214 PREVALENCE OF INFECTIOUS MARKERS IN A HETEROGENEOUS BLOOD DONOR POPULATION AT HADASSAH HOSPITALS JERUSALEM, ISRAEL

S. Mudahi-Orenstein, O. Zelig, Y. Dakosta, V. Yahalom, N. Manny (Hadassah–Hebrew University Medical Cente, Jerusalem, Israel)

P-215 WHY DO HEPATITIS C RATES CONTINUE TO DECREASE IN FIRST TIME DONORS?

F. O'Brien, W. Fan, E.B. Morris, Q. Yi, M. Goldman, M.A. Fearon, C. Infante-Rivard, J.A. Chiavetta, B. Willems, D. Pi, M. Fast, G. Delage (Canadian Blood Services, Ottawa, Canada)

P-216 BLOOD LETTING REDUCES HEPATIC INFLAMMATION IN PATIENTS AFFECTED WITH IRON OVERLOAD SECONDARY TO CHRONIC HEPATITIS HCV-RELATED

L. Paesano, M. D'Onofrio, I. Gentile, C. Viola, E. D'Agostino, M. Piazza, G. Borgia, S. Formisano (Hospital "S.G. Bosco" - ASL-Na1, Naples, Italy)

P-217 DEVELOPMENT OF A FLEXIBLE AND SENSITIVE IN-HOUSE REAL-TIME PCR ASSAY FOR THE QUANTIFICATION OF HBV DNA

D. Paraskevis, C. Haida, A. Katsoulidou, Z. Moschidis, E. Hatzitheodorou, A. Varaklioti, A. Angelos (Medical School, Athens University, Athens, Greece)

P-218 ALANINE AMINOTRANSFERASE METHOD VALIDATION DESIGN ACCORDING TO TRACEABILITY CHAIN AND SIGMA LEVEL PERFORMANCE

P. Pereira, P. Rodrigues, A. Ribeiro, S. Silva, N. Boavida (Portuguese Blood Institute, Lisboa, Portugal)

P-219 OCCULT HEPATITIS B SURVEILLANCE IN BLOOD DONATIONS IN GREECE

C.P. Politis, A. Karafoulidou, H. Theodori, A. Tsoukala, E. Andrioti, P. Tseliou, E. Zervou, L. Kavallierou, G. Martinis, O. Marandidou, A. Kaperoni, A. Hatzakis (General Athens Hospital "G. Gennimatas", Athens, Greece)

P-220 CORRELATION BETWEEN THE PREVALENCE OF ANTI-HCV POSITIVE PATIENTS AND THE NUMBER OF RECEIVED BLOOD UNITS AND DURATION OF HEMODIALYSIS TREATMENT

P.G. Poposki (Institute of Nephrology, Struga, Macedonia)

P-221 HEPANOSTIKA HBSAG ULTRA AND CONFIRMATORY ASSAY: A NEW HEPATITIS B SURFACE ANTIGEN (HBSAG) SCREENING ASSAY COMBINATION DESIGNED FOR SENSITIVE AND SPECIFIC DETECTION OF HBSAG SUBTYPES AND VARIANTS

M.H. van Roosmalen, J.J. DeJong, C. Dries, W. Haenen, J.A Hellings (BioMerieux bv, Boxtel, The Netherlands)

P-222 COST EFFECTIVENESS ANALYSIS FOR BLOOD DONOR SCREENING WITH SURROGATE PARAMETERS LIKE ALT AND NEOPTERIN

M. Schmidt, C. Drexler, M. Bayer, G. Lanzer, M.K. Hourfar, E. Seifried (German Red Cross, Frankfurt, Germany)

P-223 ANTI-HBC SEROCONVERSION IN VACCINATED AND NON-VACCINATED BLOOD DONORS – SIGN OF RECENT HEPATITIS B INFECTION ?

M. Schmidt, V. Lenz, M.K. Hourfar, W. Sireis, E. Schellenberg, W. Weichert, W.R. Willems, E. Seifried, W.H. Gerlich (German Red Cross, Frankfurt, Germany)

P-225 ONE YEAR EXPERIENCE AFTER IMPLEMENTATION OF ANTI-HBC-TESTING INTO BLOOD DONOR SCREENING IN GERMANY

M. Schmidt, M.K. Hourfar, E. Schellenberg, G.G. Geusendam, B. Siebert, A. Vosberg, T. Dengler, K. Gubbe, K. Frank, A. Karl, M. Loehr, W. Sireis, E. Seifried (German Red Cross, Frankfurt, Germany)

P-227 PREVALENCE OF SEN VIRUS INFECTION IN BLOOD DONORS IN IRAN

Z. Sharifi, M. Mahmoudian Shooshtari, A. Talebian (Research Center of Blood Transfusion Org, Tehran, Iran)

P-228 HDV INCIDENCE AMONG HBV-POSITIVE BLOOD-DONORS AND PATIENTS OF THE PIRAEUS GENERAL HOSPITAL “TZANEION”

P. Spyropoulou, M. Kaukarisiou, S. Matsagos, A. Kolokytha, C. Alepi, K. Tsalafouti, B. Panagopoulou, M. Venidi, M. Igoumenidis, L. Dadiotis (Piraeus General Hospital "Tzaneion", Piraeus, Greece)

P-229 THE PREVALENCE OF HBS AG-POSITIVE AND ANTI-HCV POSITIVE IN BLOOD DONORS

B.S. Stankovic (Institute of Transfusiology, Belgrad, Serbia)

P-230 VIROLOGY PROFILE AND SERUM PROTECTION TO HEPATITIS B OF THE STAFF OF DISTRICT GENERAL HOSPITAL OF NIKEA . PIRAEUS

S. Stefanakou, M. Kokouva, C. Drakoulis, S. Valsami, M. Papakonstantinou, E. Katsadorou, V. Fakitsa (General Hospital of Nikea, Athens, Greece)

P-231 OCCULT HBV INFECTIONS IN THE ACUTE AND CHRONIC STAGE INTERDICTED BY TRANSCRIPTION MEDIATED AMPLIFICATION (TMA) TESTING OF SMALL DONOR POOLS

P. Torres, S. Nieto, R. García-Carpio, M. Ruiz, M.A. Rodriguez, L. Barbolla, H. Zaaijer, M. Koppelman, N. Lelie (Centro de Transfusion de Madrid, Madrid, Spain)

P-232 HBV CONFIRMATORY TESTING IN BLOOD DONORS

D. Virijevic (Blood Transfusion Center, Nis, Serbia)

P-233 DETECTION OF HEPATITIS C CORE ANTIGEN AMONG BLOOD DONORS AND MULTITRANSFUSED PATIENTS IN SERBIA

D. Vucetic, M. Trkuljic, B. Balint, Lj. Tukic, M. Ljubenov, D. Jovicic, R. Graovac (Institute of Transfusiology, VMA, Belgrade, Serbia)

P-234 THE INCIDENCE OF HEPATITIS B AND C INFECTIONS IN TRANSFUSION DEPENDANT THALASSAEMIA MAJOR PATIENTS IN PAKISTAN

H.A Zaheer, M. Sufyan, K. Hasan (Pakistan Institute of Medical Sciences, Islamabad, Pakistan)

Poster Session Topic 6.3:

Blood Safety - Transfusion Transmitted Disease (TTD) - Parasites

P-235 TRACING OF ONE YEAR OF CHAGAS SCREENING AT THE CENTRO DE TRANSFUSION DE GALICIA (C.T.G.). CONCERNING A POSITIVE BLOOD DONOR

M. Abalo, M. Adelantado, C. Areal, A. Castrillo, A. Castro, J. Cid, A. Eiiras, J. Flores, J. Cabrera (Centro de Transfusion de Galicia, Santiago De Coompostela, Spain)

P-236 SEROPREVALENCE OF TRIPANOSOMA CRUZI ANTIBODIES IN BLOOD DONORS IN MADRID AREA.

M. Algora, P. Torres, B. Ariza, R. Moreno, M.L. Herrero, M.A. Martínez, M. Ruíz, I. Zuazagoitia, S. Quesada, M. Fernández, R. García-Carpio, G. Zancada, E. Corredor, L. Barbolla (Centro de Transfusion, Madrid, Spain)

P-237 CHAGAS SEROPREVALENCE IN BLOOD DONORS OF A NON ENDEMIC REGION – PERU 2003 – 2006

M. Delgado Burga, E. Manrique Valencia, E. Manrique Castagnola, N. Loayza Urcia, D. Bolivar Joo, C. Mendoza Euribe, S. Del Carpio Ortmann, I. Davila Ildefonso, M.F. López Barroso (Sociedad Peruana de Hemoterapia, Lima, Peru)

P-238 IMPLEMENTATION OF MALARIAE DISEASE SCREENING IN THE SPANISH BLOOD DONOR POPULATION. EVALUATION AND SELECTION OF SCREENING ASSAYS

R. González, B. Cerezo, L. Barea, J.L. Bueno, J.M. Rubio, E. Castro (Centro Transfusión. Cruz Roja Española, Madrid, Spain)

P-239 MALARIA LOOKBACK PROGRAM USING MALARIA-PCR IN KOREA

T.Y. Kim (Center for disease control & prevention, Seoul, South-Korea)

P-240 EVALUATION OF A STRATEGY FOR TRYPANOSOMA CRUZI SCREENING AND ITS IMPACT ON BLOOD DONATION

A. Ontañon, J.L. Arroyo, I. Romon, C. Amunarriz, V. Hermosa (Banco de Sangrey Tejidos de Cantabria, Santander, Spain)

P-241 STUDY OF THE PREVALENCE OF LEISHMANIASIS IN BLOOD DONORS FROM THE VALENCIAN COMMUNITY

M.C. Parada, M.T. Fraile, I. Llagunes, E. Ruiz, M. Calabuig, J. Villalba, J. Montoro, R. Roig (Blood Transfusion Center, Valencia, Spain)

P-242 PREVALENCE OF PALUDISM IN BLOOD DONORS IN THE VALENCIAN COMMUNITY

M.C. Parada, M.T. Fraile, M. Calabuig, J. Villalba, J. Montoro, R. Roig (Blood Transfusion Center, Valencia, Spain)

P-243 IMMUNOBLOT ASSAY USING RECOMBINANT ANTIGENS AS A SUPPLEMENTAL TEST TO CONFIRM ANTIBODIES TO TRYPANOSOMA CRUZI

O. Shah, C.-D. Chang, K. Cheng, V. Salbilla, A. Haller, N. Adya, B. Marchlewicz, A. Leiby, L. Kirchhoff, G. Schochetman, C. Hunt (Abbott Diagnostics, Abbott Park, United States of America)

P-244 PERFORMANCE CHARACTERISTICS OF THE ABBOTT PRISM TRYPANOSOMA CRUZI ANTIBODY SPECIFIC PROTOTYPE ASSAY*

A. Yem, B. Marchlewicz, L. Jiang, A. Finley-Wachter, V. Sullins, S. Dembowski, A. Kempa, D. Markley, C. Huizenga, L. Kirchhoff, A. Leiby, C. Hunt, G. Schochetman, J. Bryant, M. Rogers, K. Cheng, O. Shah (Abbott Diagnostics, Abbott Park, United States of America)

Poster Session Topic 6.4:

Blood Safety - Transfusion Transmitted Disease (TTD) - Bacterial Contamination

P-245 AN UPDATE ON ROUTINE BACTERIAL MONITORING OF PLATELETS AT THE WELSH BLOOD SERVICE

R Ahya (Welsh Blood Service, Cardiff, United Kingdom)

P-246 CLINICAL AND SEROLOGICAL PROFILE OF BLOOD DONORS WITH FALSE-POSITIVE RPR TEST

V. Bakaloudi, E. Kostopoulou, E. Ntinopoulou, E. Hassapopoulou, P. Chalkia, P. Didoudi, S. Intzepeli, V. Avgoloupi, A. Tsoukala (AHEPA University Hospital, Thessaloniki, Greece)

P-247 BACTERIAL CONTAMINATION OF APHERESIS PLATELETS TRACED TO MAIN SOURCE

A Castrillo, A. Eiras, C. Areal, M. Adelantado, M. Abalo, A. Castro, J. Cid, J. Flores, J. Cabrera (Galician Transfusion Center, Santiago De Compostela, Spain)

P-248 IMPROVEMENTS TO BLOOD CENTER MANAGEMENT BY THE IMPLEMENTATION OF PALL EBDS FOR ROUTINE BACTERIA SCREENING OF PLATELETS

R. García, A.B. Polo, L. Ruiz Ayala (Centro de Transfusión de La Rioja, Logroño, Spain)

P-249 SIX YEARS OF BACTERIAL SURVEILLANCE OF BLOOD PRODUCTS IN REGIONAL BLOOD TRANSFUSION CENTER IASI, ROMANIA (2001-2006)

D. Ilcenco (Regional Blood Transfusion Center, Iasi, Romania)

P-250 USE OF THE PLATELET PGD® TEST TO DETECT BACTERIA CONTAMINATION IN BUFFY COAT UNITS

K. Ito, M.A. Stiles, N.B. Best, K.P. Proctor, P.C. MacDonnell, J.A. Hall (Verax Biomedical Incorporated, Worcester, Ma, United States of America)

P-251 ROUTINE MONITORING OF BACTERIAL CONTAMINATION IN BLOOD PRODUCTS AS A PART OF QUALITY MANAGEMENT SYSTEM

R.J. Jovanovic (Blood Transfusion Institute, Novi Sad, Serbia)

P-252 PROCESS CHANGES RESULTING IN IMPROVED BACTERIAL SCREENING

N.D. Kalmin, S. Jones, F. Nieves, K. Myers (South Texas Blood & Tissue, San Antonio, United States of America)

P-253 EVALUATION OF THE VERSATREK AUTOMATED MICROBIAL DETECTION SYSTEM FOR THE DETECTION OF BACTERIA IN PLATELET CONCENTRATES

C.P. McDonald, A Titman, J Colvin, C. Biggs (National Blood Service, London, United Kingdom)

P-254 DRAMATIC IMPROVEMENT OF DONOR ARM DISINFECTION EFFECTIVENESS USING THE CHLORAPREP® DISINFECTION PROCEDURE

C.P. McDonald, C Biggs, B. Lees, N. Beckman, J. Kellington, L. Bissell (National Blood Service, London, United Kingdom)

P-255 MICROBIOLOGICAL MONITORING AND QUALITY ASSURANCE AT THE BLOOD TRANSFUSION INSTITUTE OF SERBIA

M.S. Milosavljevic (Blood Transfusion Institute of Serbia, Belgrade, Serbia)

P-256 COMPARISON OF A GEL TEST WITH OTHER CONFIRMATORY METHODS (FTA-ABS AND TPHA) FOR SYPHILIS IN BLOOD DONATIONS

E. Ntinopoulou, E. Kostopoulou, V. Bakaloudi, P. Chalkia, P. Didoudi, S. Intzepeli, V. Avgoloupi, E. Hassapopoulou, A. Tsoukala (AHEPA Hospital, Thessaloniki, Greece)

P-257 THE RISK OF A BACTERIAL CONTAMINATION OF HEMOCOMPONENTS MUST FORCE TRANSFUSION CENTER TO IMPLEMENT PREVENTIVE MEASURES

L. Paesano, M. D'Onofrio, S. Misso, G. Fratellanza, E. D'Agostino (Hospital "S.G. Bosco" - ASL-Na1, Naples, Italy)

P-258 COMPARISON STUDY OF TWO SCREENING TECHNIQUES FOR CHAGAS DISEASE IN BLOOD DONORS FROM THE VALENCIA REGIONAL COMMUNITY

M.C. Parada, M. Alvarez, E. Vila, C. Ramada, M. Calabuig, J. Villalba, J. Montoro, R. Roig (Blood Transfusion Center, Valencia, Spain)

P-259 NATIONAL HEALTH SERVICE BLOOD AND TRANSPLANT ( NHSBT) EXPERIENCE DURING OPERATIONAL VALIDATION OF BACTERIAL MONITORING SYSTEMS IN 2 MAJOR BLOOD CENTRES IN ENGLAND

B. Pelle, J. Jackson (NHS Blood and Transplant, Manchester, United Kingdom)

P-260 THREE YEAR REVIEW OF SYPHILIS SCREENING WITH ID-PAGIA SYPHILIS TEST

V. Polanda-Lasica, D. Martinovic (General Hospital Dubrovnik, Dubrovnik, Croatia)

P-262 DETECTION OF BACTERIAL CONTAMINATION IN APHERESIS AND BUFFY COAT PLATELET PREPARATIONS IN CANADA

M. Ramirez-Arcos, I. Martincic, C. Jenkins, S. Shimla, M. Goldman (Canadian Blood Services, Ottawa, Canada)

P-265 EVOLUTION OF SURVEILLANCE THE BACTERIAL CONTAMINATION OF PLATELETS TRANSFUSION IN A HOSPITAL

M.-D. Shi (YongKang Veterans Hospital, Tainan County, Taiwan)

P-266 INTRODUCING OF STERILITY BLOOD AND BLOOD PRODUCTS CONTROL IN BLOOD TRANSFUSION INSTITUTE NIS

S. Stevanovic, Z. Stanojkovic, A. Antic (Blood Transfusion Institute Nis, Nis, Yugoslavia)

P-267 BACTERIAL CONTAMINATION OF TRANSFUSED PLATELET COMPONENTS – EXPERIENCE OF ONE UNIVERSITY HOSPITAL

O. Zelig, C. Block, S. Mudahi-Orenstein, Y. Dakosta, N. Manny (Hadassah Medical Center, Jerusalem, Israel)

TUESDAY, JUNE 26

Poster Session Topic 6.5:

Blood Safety - Transfusion Transmitted Disease (TTD) - Nucleic Acid Amplification Technology (NAT)

P-268 THE NEED FOR NAT TESTING IN BLOOD TRANSFUSION SERVICES IN THE NEW MILLENNIUM

A. Alamiri (Ministry of Health, Sharjah, United Arab Emirates)

P-269 THE CLINICAL IMPORTANCE OF ANTI-HBC AS THE ONLY POSITIVE SEROLOGICAL MARKER OF HEPATITIS B VIRUS (HBV) AFTER THE IMPLEMENTATION OF NUCLEIC ACID TESTING IN INDIVIDUAL DONORS (ID NAT)

K. Alexopoulos, P. Tseliou ("Agios Andreas" General Hospital, Patras, Greece)

P-270 COMPARISON BETWEEN SEROLOGY AND NUCLEIC ACID TESTING RESULTS ON BLOOD UNITS

M. Alvarez, E. Vila, M. Ortiz de Salazar, J. Villalba, L. Hernández, J.A. Montoro, A. Tascón, R. Roig (Centro de Transfusión, Alicante, San Juan, Spain)

P-271 SIX MONTHS EXPERIENCE OF NAT IN THE BLOOD CENTER OF NORTHERN GREECE

V. Bakaloudi, C. Sachinidou, S. Intzepeli, E. Hassapopoulou, E. Ntinopoulou, E. Kostopoulou, P. Chalkia, P. Didoudi, V. Avgoloupi, F. Skara, A. Tsoukala (AHEPA University Hospital, Thessaloniki, Greece)

P-272 ROCHE DIAGNOSTICS COBAS S 201 FRENCH EVALUATION: RESULTS AND WORKFLOW STUDY

V. Barlet, M. Deschaseaux, I. Dupont, C. Guitton, P. Morel (EFS Rhône-Alpes, Metz-Tessy, France)

P-273 MULTI-CENTRE EVALUATION OF THE ROCHE COBAS S 201 SYSTEM: AN AUTOMATED PLATFORM FOR NAT BLOOD SCREENING

J.B. Becker, L.M. Jarvis, S. Cleland, L. Queirós, A. Aquiar, J. Azevedo, G. Aprili, F. Bressan, P. Torres, S. Nieto, A. Ursitti, J. Montoro Alberola, E. Vila, C. Ramada, P. Matthiesen (Roche Molecular Systems, Inc., Pleasanton, United States of America)

P-274 MINI-POOL NUCLEIC ACID AMPLIFICATION TECHNOLOGY(NAT) COMBINED WITH SEROLOGY : A COST EFFECTIVE WAY TO IMPROVING BLOOD SAFETY IN INDIA.

C. Chandrashekar, S. Joshi, V. Sharma (Manipal Hospital Bangalore, Bangalore, India)

P-275 AUTOMATED NAT BASED ON REAL-TIME PCR. ROUTINE SETTING AND EXTERNAL RUN CONTROL POLICY ADOPTED

A. Eiras, J. Cid, M. Abalo, M. Adelantado, C. Areal, A. Castrillo, A. Castro, J. Flores, J. Cabrera (Centro de Transfusión de Galicia, Santiago De Compostela, Spain)

P-276 EXPERIENCES IN NAT SCREENING PRIOR TO RELEASING CELLULAR COMPONENTS BY A BLOOD BANK OF ARGENTINA

C. Fornes, S. Chialina, C. Landi, M.V. Nicolorich, M. Pivetta, M.A. Raillón, E. Solis (Hospital Italiano Garibaldi Rosario, Rosario, Argentina)

P-277 COBAS S 201 SYSTEM: 7 MONTHS EXPERIENCE IN A BLOOD CENTRE

M.I. González Fraile, E. Moreno Lopez, A. Gutierrez Alonso, M. Andres Perez, M. Gomez Rubin, M.D. Blanco Martinez, G. Tejera Rodriguez, V.F. Padron Rivas (Centro de Hemoterapia de Castilla y León, Valladolid, Spain)

P-278 ANTI-HBC DETECTION IN BLOOD DONORS WITH DISCREPANT RESULTS IN ULTRIO ASSAY SCREENING

P. Grabarczyk, G. Liszewski, M. Mikulska, J. Kusmierczyk, E. Brojer (Inst. of Hematology and Transfusion Med., Warsaw, Poland)

P-280 EXTERNAL QUALITY ASSESSMENT SCHEME FOR NUCLEIC ACID TESTING OF BLOOD DONATIONS AND PLASMA.

D Jardine (National Serology Reference Laboratory, Fitzroy, Australia)

P-281 EVALUATION OF THE NEW ARCHITECT CMV IGG ASSAY IN COMPARISON TO BIOTEST CMV IGG ASSAY

J. Luhm, J. Herzogenrath, M. Hausmann, M. Ziemann, H. Hennig (Institute for Imunology and Transfusion, Lübeck, Germany)

P-282 INTRODUCTION OF HBV NAT SCREENING ON BLOOD DONATION IN ITALY AND IDENTIFICATION OF HBV OCCULT INFECTION CASES.

P. Manzini, F. Danielle, A. Pizzi, P. Milanesi, E. De Filippo, C. Balloco, M. Prina, F. Curti, C. Valpreda (A.O. S. Giovanni Battista di Torino, Torino, Italy)

P-283 CONTRIBUTION OF MULTIPLE REAL-TIME PCR IN BLOOD DONORS: A CASE OF OCCULT HBV INFECTION

G. Moreno, C. Fernández, C. Gomez, M.C. Gutierrez, T. Parrado, V. Flores, M.P. Martinez, M.A. Perez de Albeniz (Centro de Transfusión de Toledo, Toledo, Spain)

P-284 ADVANTAGES OF AN AUTOMATED SYSTEM FOR MULTIPLEXED REAL-TIME PCR SCREENING OF BLOOD DONATIONS

G. Moreno, V. Flores, M.P. Martinez, M.C. Gutierrez, T. Parrado, V. de la Rosa, M.A. Perez de Albeniz (Centro de Transfusión de Toledo, Toledo, Spain)

P-285 NUCLEIC ACID TESTING IMPLEMENTATION IN BLOOD SCREENING OF INTERMEDIATE ENDEMIC POPULATIONS OF SW GREECE

A. Mouzaki (University of Patras, Patras, Greece)

P-286 GREY ZONE UTILITY FOR MOLECULAR BIOLOGY TECHNIQUES. EXPERIENCE IN ROUTINE WORK

A. Ontañon, J.L. Arroyo, I. Romon, C. Amunarriz, V. Hermosa (Banco de Sangrey Tejidos de Cantabria, Santander, Spain)

P-287 WHICH INDIVIDUAL DONATION (ID)-NAT TEST ALGORITHM HAS TO BE FOLLOWED FOR OPTIMAL SPECIFICITY AND MAXIMUM RECOGNITION OF BLOOD DONORS WITH OCCULT HBV INFECTION?

A. Ontañon, J.L. Arroyo, I. Romon, C. Amunarriz, V. Hermosa (Banco de Sangrey Tejidos de Cantabria, Santander, Spain)

P-288 ANALYTICAL SENSITIVITY AND SPECIFICITY OF COBAS TAQSCREEN WEST NILE VIRUS TEST ON COBAS S 201 SYSTEM

A. Pai, K. Malhotra, S. Austin, M. Kubik, T. May, S. Shah, J. Novotny (Roche Molecular Diagnostics, Inc., Pleasanton, Ca, United States of America)

P-289 SIMULTANEOUS DETECTION OF THREE VIRAL GENOMES IN BLOOD DONOR SCREENING WITH THE USE OF A SINGLE MOLECULAR ASSAY

E. Perna, M. D'Onofrio, L. Paesano, E. D'Agostino, G. Ciardiello, F. Ferruzzi, S. Formisano (University "Federico II", Naples, Italy)

P-290 EVALUATION AND ONE-YEAR EXPERIENCE USING HCV NAT BASED ON NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION FOR SCREENING BLOOD DONATIONS IN ARGENTINA

E. Rodriguez, A. Gichón, L. Tomasone, M.E. Acevedo, R. Fernández (Fundación Hemocentro Buenos Aires, Buenos Aires, Argentina)

P-291 AUTOMATED NAT FOR BLOOD SCREENING OF 6 VIRUSES

W.K. Roth, J. Bux, Th. Müller, F. Weinauer (GFE Blut mbH, Frankfurt Am Main, Germany)

P-292 CORRELATION OF ID-NAT RESULTS WITH CONFIRMATORY TESTING AMONG HCV SEROPOSITIVE GREEK BLOOD DONORS

A. Varaklioti, A. Kontopanou, Z. Moschidis, G. Pantelaki, V. Tatsi, A. Kapsalis, A. Karafoulidou (Laiko General Hospital, Athens, Greece)

P-293 IMPLEMENTATION OF PROCLEIX TIGRIS SYSTEM FOR NUCLEIC ACID TESTING OF THE BLOOD DONATIONS IN A TRANSFUSION CENTER

E. Vila, M. Alvarez, J. Villalba, C. Ramada, I. Llagunes, D. Planelles, N. Puig, J.A. Montoro, R. Roig (Centro de Transfusión de la C.Valenciana, Valencia, Spain)

P-294 SENSITIVITY ANALYSIS OF THE PROCLEIX ULTRIO-TIGRIS SYSTEM FOR NUCLEIC ACID TESTING IN A SPANISH TRANSFUSION CENTER

E. Vila, J. Villalba, C. Ramada, E. Ruiz, M. Sarrion, R. Navarro, D. Planelles, N. Puig, J.A. Montoro, R. Roig (Centro de Transfusión de la C.Valenciana, Valencia, Spain)

P-295 EARLY EXPERIENCE WITH INDIVIDUAL HBV, HCV, HIV-1 NAT TESTING IN BLOOD DONATIONS IN NORTHWESTERN GREECE

E. Zervou, M. Vini, A. Tzolou, E. Xanthi, F. Karabini, E. Britsas, A. Soukouvelou, O. Valari, K. Ziciadis (University Hospital of Ioannina, Ioannina, Greece)

P-296 HIGH PREVALENCE OF CYTOMEGALOVIRUS DNA IN PLASMA OF BLOOD DONORS IN CONNECTION WITH SEROCONVERSION

M. Ziemann, S. Krüger, A.B. Maier, A. Unmack, S. Görg, H. Hennig (University of Lübeck, Luebeck, Germany)

Poster Session Topic 7.0:

Pathogen reduction/Inactivation

P-297 THE EFFECT OF PHOTOCHEMICAL TREATMENT (PCT) WITH AMOTOSALEN AND UVA LIGHT ON COAGULATION FUNCTION OF CONCURRENT PLASMA FROM PLATELET APHERESIS

E. Castro, J.L. Bueno, M. Díaz-Ricart, M. Palomo, G. Escolar (Centro Transfusión. Cruz Roja Española, Madrid, Spain)

P-298 THREE YEARS OF EXPERIENCE WITH THE INTERCEPTTM BLOOD SYSTEM FOR APHERESIS PLATELETS IN ROUTINE USE

E. Castro, J.L. Bueno, P. Rodríguez, L. Barea, R. González (Centro Transfusión. Cruz Roja Española, Madrid, Spain)

P-299 STORAGE OF APHERESIS PLATELET CONCENTRATES TREATED WITH INTERCEPT SYSTEM

Z. Cermakova, J. Marcalikova, M. Stachelova (Faculty Hospital, Ostrava, Czech Republic)

P-300 LEVELS OF COAGULATION FACTORS IN FRESH FROZEN PLASMA OBTAINED FROM WHOLE BLOOD DONATIONS AND PREPARED WITH TWO PHOTOCHEMICAL TREATMENT METHODS

J. Cid, O. Magallon, M. Claparols, A. Pinacho, P. Ortiz, L. Puig, R.P. Pla (Banc de Sang i Teixits, Barcelona, Spain)

P-301 IMPACT OF PHOTOCHEMICAL PATHOGEN INACTIVATION TREATMENT (INTERCEPT BLOOD SYSTEM™ FOR PLATELETS, IBSP) ON THE RESPONSE TO TRANSFUSION WITH 6 AND 7- DAY OLD COMPONENTS

L. Defoin, C. Doyen, C. Debry, M. Goffaux, N. Messe, M. Van Hooydonk, L. Corash, J.C. Osselaer (Cliniques Universitaires de Mont Godinne, Yvoir, Belgium)

P-302 EVALUATION OF A NOVEL ILLUMINATION DEVICE FOR THE TREATMENT OF MB-PLASMA

U. Gravemann, M. Behague, S. Reichenberg, H. Mohr, W.H. Walker, T. Verpoort, T.H. Mueller (Blood Center of the German Red Cross, Springe, Germany)

P-303 IMPLEMENTATION OF PHOTOCHEMICAL PATHOGEN INACTIVATION (INTERCEPT BLOOD SYSTEM™ FOR PLATELETS) IN A REGIONAL BLOOD CENTER

H. Isola, D. Kientz, M.L. Wiesel, M. Laforêt, P. Ohlmann, C. Waller, I. Mendel, J.P. Raidot, G. Kandel, J.P. Cazenave (Établissement Français du Sang-Alsace, Strasbourg, France)

P-304 EFFECT OF PHOTO INACTIVATION WITH METHYLENE BLUE ON SEROLOGICS TESTS RESULTS

A.I. Jimenez Del Bianco, J. Alfaro, R. Valentin, V.P. Padron (Centro Hemoterapia Castilla y Leon, Valladolid, Spain)

P-305 ONE YEAR OF ROUTINE USE OF THE INTERCEPT BLOOD SYSTEM FOR PLATELET PATHOGEN INACTIVATION : PRODUCT PREPARATION AND CLINICAL EVALUATION

G. Lambermont, N. Cellier, R. De Meuter (Belgian Red Cross, Brussels, Belgium)

P-306 OUR NINE YEARS EXPERIENCE IN PLASMA INACTIVATION

L. Larrea, M. Calabuig, M.A. Soler, P. Solves, V. Mirabet, R. Roig (Centro Transfusion Comunidad Valencia, Valencia, Spain)

P-307 INACTIVATION OF SMALL NON-ENVELOPED VIRUSES IN PLASMA REDUCED PLATELET CONCENTRATES BY IRRADIATION WITH SHORTWAVE ULTRAVIOLET LIGHT

H. Mohr, U. Gravemann, J. Knüver-Hopf, F. Tolksdorf, W.H. Walker, T.H. Müller (Blood Center of the Greman red Cross Cha, Springe, Germany)

P-308 CHARACTERIZATION OF ANTIBODIES TO RED CELLS PREPARED WITH S-303 PATHOGEN INACTIVATION TREATMENT

A. North, G. Castro, A. Erickson, D. Cook, L. Corash (Cerus Corporation, Concord, United States of America)

P-309 DEMONSTRATION OF AN S-303-INDUCED IMMUNE RESPONSE IN A NAÏVE RABBIT MODEL OF CHRONIC TRANSFUSION USING A SENSITIVE FLOW CYTOMETRY ASSAY

A. North, V. Lee, A. Erickson, N. Moore (Cerus Corporation, Concord, United States of America)

P-310 COAGULATION FUNCTION IN FRESH FROZEN PLASMA PREPARED WITH TWO PHOTOCHEMICAL TREATMENT METHODS

C. Debry, M. Goffaux, E. Dubuc, B. Chatelain, M.C. Vandendaele, J.C. Osselaer (Cliniques Universitaires de Mont Godinne, Yvoir, Belgium)

P-311 ADVERSE REACTIONS ASSOCIATED WITH METHYLENE BLUE INACTIVATED FRESH FROZEN PLASMA VS. STANDARD FFP

C.P. Politis, L. Kavallierou, S. Hantziara, V. Triantaphyllou, C.R. Richardson (General Athens Hospital "G. Gennimatas", Athens, Greece)

P-312 CHARACTERISTICS OF MACOPHARMA THERAFLEX MB-PLASMA

S. Reichenberg, U. Gravemann, P. Pohler, W.H. Walker (Maco Pharma International GmbH, Langen, Germany)

P-313 INACTIVATION OF CHIKUNGUNYA VIRUS IN PLATELETS AND PLASMA USING THE INTERCEPT BLOOD SYSTEM™

S.W. Sawyer, A. Sampson-Johannes, T. Dubensky, J. Kinsey, D.L. Vanlandingham, K. Tsetsarkin, S. Higgs (Cerus Corporation, Concord, Ca, United States of America)

P-314 ROBUSTNESS OF VIRAL INACTIVATION IN HIGH-DOSE INTERCEPT™ PLATELETS

S.W. Sawyer, L. Corten, D. Hanson, L. Lin (Cerus Corporation, Concord, Ca, United States of America)

P-315 PLATELET CONCENTRATES TREATED FOR PATHOGEN INACTIVATION USING THE INTERCEPTTM BLOOD SYSTEM: MANUFACTURING AND QUALITY CONTROL OF INTERCEPT PLATELETS IN ROUTINE

P. Schlenke, W. Hagenah, S. Andresen, M. Bauhaus, L. Lin, T. Wagner, H. Kirchner (University of Luebeck, Luebeck, Germany)

P-316 PLATELET COMPONENTS TREATED WITH PATHOGEN INACTIVATION USING THE INTERCEPTTM BLOOD SYSTEM: CLINICAL OUTCOMES OF THE FIRST SINGLE-CENTRE CLINICAL TRIAL IN GERMANY

P. Schlenke, W. Hagenah, S. Andresen, M. Bauhaus, D. Sundin, L. Lin, L. Corash, T. Wagner, H. Kirchner (University of Luebeck, Luebeck, Germany)

P-317 EVALUATION OF THE ARCHITECT CMV IGG ASSAY IN A SWISS BLOOD BANK- A PROSPECTIVE COMPARISON WITH THE AXSYM CMV IGG ASSAY

C. Stebler, M. Rüesch, C. Doepfner, M. Santoro, L. Infanti (Blood Transfusion Center Basel, Basel, Switzerland)

P-318 A COMPARISON OF TRANSFUSION OF STANDARD AND PATHOGEN INACTIVATED (INTERCEPTTM) PLATELETS WITH REGARDS TO CCI AND ACUTE TRANSFUSION REACTIONS IN HEMATOLOGICAL PATIENTS

C. Stebler, L. Infanti, M. Rüesch, H. Lüscher, S. Job, J. Pfenninger, A. Gratwohl, J. Tobler (Blood Transfusion Center Basel, Basel, Switzerland)

P-319 PATHOGEN INACTIVATION OF DOUBLE DOSE APHERESIS PLATELETS USING THE INTERCEPT TM BLOOD SYSTEM: LOGISTICAL AND FINANCIAL COST BENEFITS AND CLINICAL EFFICACY

C. Stebler, M. Rüesch, M. Santoro, H. Lüscher, S. Job, J. Pfenninger, L. Infanti (Blood Transfusion Center Basel, Basel, Switzerland)

P-320 THERAFLEX UV PLATELETS: A NOVEL TECHNIQUE FOR PATHOGEN INACTIVATION AND ITS EFFECT ON THE QUALITY OF PLATELET CONCENTRATES

F. Tolksdorf, W.H. Walker, H. Mohr, U. Gravemann, T.H. Müller (MacoPharma International GmbH, Langen, Germany)

P-321 COMPARISON OF IMMUNOMODULATIVE SUBSTANCES AND SCD40L LEVELS IN LEUKOREDUCED, PHOTO-CHEMICALLY PATHOGEN INACTIVATED VS. UNTREATED PLATELET CONCENTRATES

A. Vetlesen, M.R. Mirlashari, C.A. Akkoek, J. Kjeldsen-Kragh (Ullevaal University Hospital, Oslo, Norway)

P-322 BACKGROUND FOR IMPLEMENTATION OF SINGLE DOSE PLASMA PATHOGEN REDUCTION TECHNOLOGY IN RUSSIAN BLOOD SERVICE

E. Zhiburt, M. Gubanova, A. Khrustalev, S. Reichenberg, A. Shchepetov (Federal Blood Center, Moscow, Russian Federation)

Poster Session Topic 8.1:

Immunohaematology - Red Cell Immunology

P-323 DOES EXISTE AN ALTERNATIVE RECEPTOR TO P. VIVAX BEYOND DUFFY SYSTEM?

S. Albuquerque, E. Carvalho (Amazonas Blood Center, Manaus, Brazil)

P-324 RBC ALLOIMMUNIZATION IN CHRONIC TRANSFUSION PATIENTS (THALASSEMICS)

A. Azarkeivan, M.H. Ahmadi, A. Gharebaghian, S. Nasizadeh, S. Zolfaghari, M. Maghsoodlu, M.B. Ayoub (Iranian Blood Transfusion Organization, Tehran, Iran)

P-325 THE FREQUENCIES OF ABO BLOOD GROUPS AND RHESUS FACTOR AMONG THE POPULATION OF ALBANIA

E. Berberi, N. Borici, Dh. Rrugji, Xh. Xhango, V. Duro, V. Gjylameti, I. Seferi (National Blood Transfusion Centre, Tirana, Albania)

P-326 ABH ANTIGENS EXPRESSION AND SECRETOR STATUS OF PATIENTS WITH ORAL LESIONS

C. Biondi, C. Campi, L. Escovich, A. Racca, L. Racca, S. García Borrás, C. Cotorruelo (Universidad Nacional de Rosario, Rosario, Argentina)

P-327 MOLECULAR GENETIC ANALYSIS OF THE FUT2 GENE

C. Biondi, V. Valdez, A. Racca, S. García Borrás, L. Racca, C. Cotorruelo (Universidad Nacional de Rosario, Rosario, Argentina)

P-328 BLOOD GROUP AUTOMATION: BE AWARE OF PITFALLS!

A.G. van den Bos, J. Busser, V.M.J. Novotny (Radboud Univ. Nijmegen Medical Centre, Nijmegen, The Netherlands)

P-329 PERFORMANCE OF AUTOMATED ANTIBODY SCREENING BY THE ERYTHROCYTE-MAGNETIZED TECHNOLOGY COMPARED TO GEL TESTS

C. Bouix, C. Bertaux, M.C. Calloix, V. Godefroy, N. Peyric (Etablissement Français du Sang, Nimes, France)

P-330 IMPORTANCE OF ALLOGENEIC ADSORPTION TO DETERMINE THE INCIDENCE OF RED CELL ALLOANTIBODIES UNDERLYING WARM AUTOANTIBODIES

S.C. Castilho, G.G. Guasti (HEMORIO, Rio De Janeiro, Brazil)

P-331 PROBLEMS IN MANAGEMENT OF TRANSFUSION IN PATIENTS WITH MULTILPLES ANTIBODIES AND WITH ANTIBODIES TO HIGH FREQUENCY ANTIGENS

S.C. Castilho (HEMORIO, Rio De Janeiro, Brazil)

P-332 WEAK RHD TYPES IN DENMARK, DO SEROLOGY AND GENETICS CORRELATE?

M.C. Christiansen, B.S. Sørensen, N. Grunnet (Aarhus University Hospital, Skejby, Aarhus N, Denmark)

P-333 USE OF 0.8% CELL SUSPENSION FOR CROSSMATCHING BY IAT-IS THIS A MORE SENSITIVE METHOD COMPARED TO 3% CELL METHOD?

E.C. Clarke, J. Berryman, M. Scully, A. Nathwani (UCLH NHS Foundation Trust, London, United Kingdom)

P-334 A CASE REPORT OF A PREGNANCY INVOLVING ANTI-INB AND FACTOR V LEIDEN

Z. Daw, A. Chung, J. Cote, M. Tokessy, J. Bormanis, G. Tawagi, A. Giulivi (Ottawa Hospital, Ottawa, Canada)

P-335 PERFORMANCE STUDY OF ANTIBODY SCREENING TEST USING THE ERYTHROCYTE MAGNETIZED® TECHNOLOGY IN COMPARISON WITH GEL FILTRATION TESTS

M. Delamaire, S. Flageul, S. Derouiniot, G. Semana (EFS, Rennes, France)

P-336 THE FIRST ITALIAN REPORT OF AN ANTI- JOHN MILTON HAGEN (JMH) ANTIBODY, OF YET UNDEFINED CLINICAL SIGNIFICANCE, IN AN OLD WOMAN

A. Della Corte, L. Paesano, M. D'Onofrio, F. Varricchio, G. Di Domenico, E. Santoro, G.M. Leonardi, M. Mottola, C. Isernia, V. Zannettone, E. Picardi (Hospital "S. Giovanni Bosco", Naples, Italy)

P-337 A CLUE TO THE BASIS OF CIS-AB PHENOTYPE WITH HDN OCCURRENCE

Z.H. Deng, Y.W. Ye, Q. Yu, Y.Q. Su, Y.L. Liang, L. Lu, W.G. Zhu, B.C. Yang, S.M. Zhou (ShenZhen Blood Center, Shenzhen, China)

P-338 IDENTIFICATION OF THE RARE AEL PHENOTYPE IN AN ITALIAN FAMILY

G. Di Domenico, G.M. Leonardi, M. Mottola, C. Isernia, E. Santoro, A. Della Corte, M. D'Onofrio, L. Paesano, F. Varricchio, S. De Martino, E. Picardi (Immunohematology Service, S.Giovanni Bo, Napoli, Italy)

P-339 CHARACTERIZATION OF AN IMMUNE ANTI-P1 ANTIBODY IN A SUBJECT WITH MONOBLASTIC ACUTE LEUKAEMIA: A CASE REPORT

G. Di Domenico, M. D'Onofrio, L. Paesano, G.M. Leonardi, E. Santoro, A. Della Corte, M. Mottola, C. Isernia, F. Varricchio, S. De Martino, F. De Felice, F. Giardinelli, E. Picardi (Immunohematology Service, S.Giovanni Bo, Napoli, Italy)

P-340 CELLBIND SCREEN MICRO COLUMN AFFINITY TEST: RESULTS OF A MULTI CENTER TRIAL

E.M.M. van der Donk, L. De Jong, L. Visser, R. Melsert, P. Engelfriet (Sanquin Blood Supply, Amsterdam, The Netherlands)

P-341 ANTI-LAN IN A WOMAN WITH THE RARE LAN NEGATIVE PHENOTYPE

A. Duran, V. Teixeira, H. Hein (Instituto Portugues do Sangue, Porto, Portugal)

P-342 AUTOIMMUNE HAEMOLYTIC ANAEMIA IN THE CHILD WITH OVARIAN DERMATOID CYST

J. Fabijanska-Mitek, A. Adamowicz-Salach, H. Lopienska (Medical Centre of Postgraduate Education, Warsaw, Poland)

P-343 IMMUNOHEMATOLOGICAL EVALUATION OF AINT EXPRESSION BY OPTICAL METHODS

M. Garcia Rosasco, J. Valverde (Universidad Nacional de Rosario, Rosario, Argentina)

P-344 ANTIGEN SPECIFIC IMMUNOADSORPTION AND IMMUNOSUPPRESSIVE THERAPY TO UNDERGO ABO INCOMPATIBLE KIDNEY TRANSPLANTATION

M. Gavalaki, H. Theodoropoulou, Th. Adraktas, E. Kalfa, Z. Galani, D. Stamatiadis, J.N. Boletis, A. Karafoulidou (Laikon General Hospital, Athens, Greece)

P-345 MICROPLATE RH (D) NEGATIVE BLOOD GROUP: A COMPARATIVE STUDY OF TWO DIFFERENT REACTIVES IN A BLOOD CENTRE

M.I. González Fraile, M. Gomez Martinez, N. Holgado Ballesteros, R. Sanchez Hernandez, A. Rodriguez Manso, M.A. Moya San Pedro (Centro de Hemoterapia de Castilla y León, Valladolid, Spain)

P-346 ANALYSIS OF A SURFACE OF ENZYME TREATED RED BLOOD CELLS

A. Hyono, T. Mazda, H. Okazaki, K. Tadokoro, H. Ohshima (Tokyo University of Science, Chiba, Japan)

P-347 IDENTIFICATION OF ALLOANTIBODIES IN MULTIPLY TRANSFUSED PATIENT AND PREVENTION OF ACUTE HEMOLYTIC TRANSFUSION REACTION: THE CROSS -MATCH WEIGHT

C.I. Isernia, G. Di Domenico, G.M. Leonardi, A. Della Corte, E. Santoro, M. Mottola, M. D'Onofrio, L. Paesano, F. Varricchio, S. De Martino, F. De Felice, F. Giardinelli, E. Picardi (SIT S. Giovanni Bosco, Napoli, Italy)

P-348 ANTI-U-LIKE AS AN ALLOANTIBODY IN U- AND U+VAR INDIVIDUALS

D. Janvier, Y. Lam, J. Babinet, R. Djoudi, P. Bierling (Etablissement Français du Sang, Paris, France)

P-349 AN AUTOANTIBODY TO A HIGH-INCIDENCE ANTIGEN OF GLYCOPHORIN B, SELECTIVELY DESTROYED BY CHYMOTRYPSIN AND PRONASE

D. Janvier, D. Boyeldieu, R. Djoudi, P. Bierling (Etablissement Français du Sang, Paris, France)

P-350 PRELIMINARY RESULTS OF BLOOD GROUP TYPING IN VOLUNTARY BLOOD DONORS USING MICROPLATE TECHNIQUE

S.K. Kolundzija, M.J. Jovicic, V.D. Damjanovic, S.D. Draskovic (National Blood Transfusion Institute, Belgrade, Serbia)

P-351 SCREENING OF IRREGULAR ANTIBODIES IN BLOOD DONORS: ANALYSIS OF TEST RESULTS FOR THE PERIOD 2005 - 2006 AT THE BLOOD TRANSFUSION INSTITUTE NOVI SAD

M. Krga-Milanovic, N. Bujandric, S. Bogdanovic (Blood Transfusion Institute Novi Sad, Novi Sad, Serbia)

P-352 REVIEW OF ALLOIMUNIZATION IN THE HOSPITAL PATIENTS COPMARISON OF ANTIBODY DETECTION BETWEEN TUBE AND GEL METHODS (1996.-2006.)

S. Lisulov, R. Jovanovic (Blood Transfusion Institute, Novi Sad, Serbia)

P-353 SEROLOGICAL DETECTION OF DEL ANTIGEN USING A MONOLAYER COAGGLUTINATION TECHNIQUE ON MICROPLATES

F. Llopis, F. Arriaga, N. Puig, I. Ródenas, T. Oliva (Centro de Transfusión de Valencia, Valencia, Spain)

P-354 INCIDENCE OF DELAYED HEMOLYTIC AND SEROLOGIC TRANSFUSION REACTIONS

T.M. Makarovska-Bojadzieva, B.M. Blagoevska, S.V. Stefanovska, N.I. Nikoloska, R.G. Grubovik, E.V. Velkova (Institute of Blood Transfusion, Skopje, Macedonia)

P-355 ANTI-D IMMUNIZATION IN A D-POSITIVE MOTHER

M.P. Martinez Badas, F. Garcia Sanchez, G. Moreno Jimenez, M.A. Rodriguez Granado, M.V. Flores Sanz, P. Torres Sardina, M.A. Perez de Albéniz, L. Barbolla Garcia (Centro de Transfusion de Toledo, Toledo, Spain)

P-356 CLINICAL IMPORTANTANCE OF RED CELL ALLOANTIBODIES DETECTED IN 10 YEARS PERIOD IN GENERAL HOSPITAL IZOLA

S. Maver, I. Kramar, V. Galvani (General Hospital Izola, Izola, Slovenia)

P-357 ABO GROUPING - SEROLOGICAL DETECTION OF A MIXED FIELD REACTION WITHIN THE UK, PORTUGAL AND DENMARK

C. Milkins, J White, M Rowley (UK NEQAS, Watford, United Kingdom)

P-358 ASSESSMENT OF SUBCASSES IGG1 AND IGG3 AND THEIR RELANTIONSHIP WITH RISK OF HEMOLYSIS IN IGG CLASS DIRECT ANTIGLOBLULINE TEST POSITIVE PATIENTS

C. Morante Pombo, J.M. Garcia Gala, P. Rodriguez Vicente, S. Ortiz Saez, M. Palicio Martinez, A. Fernandez Moreno, S. Vazquez Aller (Hospital Universitario Central de Asturi, Oviedo, Spain)

P-359 PREVALENCE AND SPECIFICITY OF IRREGULAR ERYTHROCYTE ANTIBODIES IN PREGNANT WOMEN IN TWO INSTITUTIONS OF ROSARIO ARGENTINA

M.V. Nicolorich, S. Chialina, C. Fornes, L. Gonzalez, M. Pivetta, M.A. Raillon, E. Solis (Hospital Italiano Garibaldi Rosario, Rosario, Argentina)

P-360 COMPARISON OF GEL TEST AND TUBE TEST TECHNIQUE FOR ISOAGGLUTININS TITRATION

M.C.Z. Novaretti, S. Peres Navarro, S. Leao Bonifacio, P.E. Dorlhiac-Llacer, D. de Alencar Fischer Chamone (Fundaçao Pro-Sangue Hemocentro SP, Sao Paulo, Brazil)

P-361 EVALUATION OF A NEW METHOD–ERYTHROCYTES MAGNETISED TECHNOLOGY- FOR BLOOD GROUPING, PHENOTYPNG & ANTIBODY SCREENING

P. Ch. Pappa, K. Farmaki, A. Kouyia, M. Savvanos, A. Tarnara, I. Tzoumari, A. Vourtsi (Blood Transfusion Service, Corinth, Greece)

P-362 A SEVERE CASE OF HYDROPS OF IMMUNE ETHIOLOGY IN A NEONATE

M.P. Paunovic, Lj.T.S. Tomas Suput, B.J.O. Jankovic Orescanin (CHC "Zvezdara", Belgrade, Serbia)